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SUMMARY
The e f fe c t  of combinations of n ic o t in ic  acid, in su lin  and 
tryptophan on serotonin metabolism in d i f fe re n t  parts o f the brain  
of adu lt female ra ts  have been investigated. Tryptophan, 5-HT, 5-HIAA 
and tryptophan-hydroxylase were measured in the fo reb ra in , cerebellum 
and brain stem. The e f fe c t  of a f u l l  combined treatment on behaviour 
was also investigated .
The adm inistration of n ic o t in ic  acid and insu lin  did not change 
the  concentrations o f  to ta l  and f re e  tryptophan in the plasma. The 
treatment increased the tryptophan concentration in the brain stem 
and in the cerebellum, but caused no change in the fo reb ra in .  The 
concentration of 5-HT was reduced in the brain stem, but not in the 
forebra in  or in the cerebellum and the treatment had no e f fe c t  on 
5-HIAA in any parts of the b ra in . Combining n ic o t in ic  acid or in su lin  
with tryptophan reduced the tryptophan concentration in the fo reb ra in ,  
whereas i t  raised the concentration o f tryptophan in the cerebellum.
Full combined treatment caused a f a l l  in to ta l  and f re e  t ry p to ­
phan concentration in the plasma on week 4. The tre b le -trea tm en t  
raised the tryptophan concentration in the cerebellum and in the  
brain stem on the week 3. The concentration of 5-HT was reduced in 
the cerebellum on the week 2 onwards, whereas tha t in the fo rebra in  
was on week 5. In the cerebellum, the concentration of 5-HIAA was 
lower on the week 4 and in the forebra in  i t  was lower on week 5.
The a c t iv i t y  of tryptophan-hydroxylase was lower in the brain stem 
and cerebellum a f te r  three weeks of t re b le -trea tm en t,  despite the 
increase in a c t iv i t y  of the enzyme with increasing age.
Plasma concentration of methionine and isoleucine was reduced in 
the animals treated  with n ic o t in ic  acid and giving insu lin  prevented 
th is  change. The tre b le -trea tm en t also reduced the concentrations of  
tyros ine  and phenylalanine in the plasma
The concentrations of tryptophan in the brain stem and cerebellum  
were p o s it iv e ly  corre lated  with to ta l  plasma tryptophan and were 
negative ly  corre la ted  with the r a t io  of free plasma tryptophan to the 
sum of other neutral amino acids. The concentration of NEFA was 
p o s it iv e ly  corre la ted  with f re e  tryptophan in the plasma.
The locomotor a c t iv i t y  of the animals was in h ib ited  a f te r  two 
weeks t re b le -tre a tm e n t,  and the condition was accompanied by an 
increase in defensive behaviour.
The resu lts  have indicated th a t  serotonin metabolism in d i f f e r e n t  
parts of the brain responds in d i f fe r e n t  way's to n u t r i t io n a l  fac tors  
and tha t  these changes may be associated with modifications of the  
functioning of the p a r t ic u la r  regions.
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CHAPTER 1 
INTRODUCTION
INTRODUCTION
The mammalian brain is a highly complex organ with many anatomically  
d is t in c t  structures performing specialised functions and ye t  forming an 
in tegrated system. Gross examination shows that i ts  substance can be 
divided into  grey and white m atter. Grey matter contains the c e l l  bodies 
of the neurones and white matter owes its  appearance to the f a t t y  nature  
of the myelin surrounding the nerve axons. H is to lo g ic a l ly  a number of  
d i f fe r e n t  types of c e l ls  may be distinguished in the bra in . Neurones 
are the exc itab le  nerve c e l ls ,  w h ils t  the various types of g l ia  c o n tr i ­
bute to the supporting structure and n u tr it io n  of the neurones. The 
a c t iv i t y  and w ell-being of each s tructura l e n t i ty  is  contro lled  by i t s  
metabolism so th a t  there is an in tegration  of structure and metabolism 
with function .
The brain contains a number of types of g l ia l  c e l ls .  The membranes 
of the oligodendroglia form the myelin sheath whereas astrocytes besides 
providing support are thought to be concerned with n u t r i t io n ,  possibly  
by acting as mediators in the transport of se lec t ive  nu tr ien ts  from the 
c irc u la t io n  through a 'blood brain b a r r ie r '  to the neurone (Wurtman & 
Fernstrom, 1974). G lia  a lso-p lay a ro le  in synaptic regulation  by e i th e r  
releasing or absorbing neurotransmitter from the neurone (Rose, 1958).
The re la tionsh ips  of n u tr i t io n  to brain growth and function are of 
importance in malnourished ch ildren . M aln u tr it ion  may be primary, as in 
the case of protein-energy m alnutrit ion  (PEM), or secondary, as a con­
sequence of malabsorption .or metabolic disorders. In addition to the 
e ffe c ts  of postnatal changes in n u t r i t io n ,  growth and development may 
be a ffected  prenat.ally and give r is e  to the b ir th  of a 'sm all- fo r-da tes '(S FD )  
in fa n t .  The magnitude of these e ffe c ts  and the p o s s ib i l i ty  of re h a b i l -
i ta t io n  vary with the timing and severity  o f the in s u l t .  Thus, an 
understanding of the programme of brain growth is fundamental to an 
appreciation of the importance of n u tr i t io n  in re la t io n  to permanent 
sequelae of m a ln u tr it io n .
1.1 N u tr it io n  and brain' growth
1 .1 .1 .  . The growth o f  the brain
The timing of period of maximal growth, or ‘ growth spurt' o f the  
brain in re la t io n  to b ir th  is species spec if ic  (Davison & Dobbing, 1966) 
The 'growth spurt' of the guinea pig brain ( F ig . 1.1) is mainly p rena ta l,  
w h ils t  th a t  of the r a t  brain is  postnatal. The growth spurt of the 
human brain on the other hand is p e r in a ta l ,  as also is th a t  of pig brain
Human — —' Months
R a t   Days
Guinea p i g   Days
Dog -  Weeks
-  Weeks
c n
CL)
-3.5 -30 -  25 -20  -15 .-10  -5
B irthAge Age
Fig.1.1.Curves of the ra te  of the .b ra in  growth in re la t io n  to 
b ir th  in d i f f e r e n t  species. Values are expressed as weight 
increment (percentage of adult wet weight as brain) per u n it  
period of time (Davison & Dobbing, 1968).
Davison and Dobbing (1966) suggested tha t the period during which 
the growth spurt occurred constituted a 'vulnerable period' during which 
any fa c to r  which in te rfe red  with brain growth would be l ik e ly  to have a 
permanent e f fe c t  on the growth o f  the s tructura l components of the b ra in .  
Moreover, the more nearly  the in s u lt  occurred to the timing of the peak 
ra te ,  the smaller i t  would need to be to have a permanent e f fe c t . .
Studies of the growth and development of s tructu ra l components in the  
brain are made eas ier by the use of chemical markers, i . e .  substances 
which exc lus ive ly  or predominantly occur in spec if ic  structures.
1 .1 .2 .  The use of 'chemical markers'
DNA is s p e c if ic a l ly  located in c e l l  nuclei and thus the amount of  
DNA in an organ gives a measure of the number o f nuclei provided th a t  
each nucleus contains the d ip lo id  number of chromosomes. S-100 prote in  
appears to be sp ec if ic  fo r  g l ia l  c e l ls  (Davison, 1977), w h ils t  cerebrosides, 
cerebroside sulphatide and cholesterol are r e la t iv e ly  concentrated in 
myelin (Cuzner, e t  a l . ,  1965). Gang!iosides, estimated as N -ace ty l-  
neuraminic acid (NeuNAC), have been used as an index of d en d r it ic  devel­
opment (Merat & Dickerson, 1974). The r a t io  of protein : DNA has been 
used to ind icate  the c e l l  s ize (Winick, et. a l . ,  1970).
1 .1 .3 *  The e f fe c t  of m a lnu tr it ion  on c e l lu la r  growth
The growth of the human brain l ik e  th a t  o f  other organs is  
i n i t i a l l y  by hyperplasia. M u lt ip l ic a t io n  of neurones occurs rap id ly  
up to an age of about 18 weeks gestation . ( F ig .1 .2 ) Further increase in 
the number of c e l ls  is  probably due to m u lt ip l ic a t io n  of g l ia l  c e l ls .
The age at which th is  process ceases in man is not at present known.
The increase in c e l l  number occurs more ra p id ly  and ceases e a r l i e r  in
(a )
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Fig. 1.2 (a) Total DNA-P, equivalent to to ta l  c e l l  number in the human
forebra in  from 10 weeks gestation to 4 months a f te r  b ir th
(b) A semi-logarithmic p lo t  of the data in (a)  
(Dobbing & Sands, 1973).
the cerebellum than in e i th e r  the forebra in  or brain, stem. This 
accounts fo r  the fa c t  th a t  fo llow ing in tra u te r in e  undernutrit ion  the 
number of neurones is more severely depleted in the cerebellum than 
in the cerebrum or brain stem (Chase, et al.. ;  1972)
In in fan ts  who were severely malnourished during the f i r s t  year  
of l i f e ,  the DNA content of the cerebellum, cerebrum and brain stem 
were reduced to a s im ila r  extent (Winick, e t  a l .., 1970). Moreover, 
these workers also reported th a t  in older ch ild ren , chronic m alnutr it ion  
resulted in a reduction in c e l l  s ize  as well as c e l l  number.
1 .1 .4 .  The e ffec t-  of^m alnutrition  on m.yelin
The accumulation of cerebroside sulphatide (a  marker fo r  myelin) 
takes place over a r e la t i v e ly  short period, during which myelin is  most 
rap id ly  formed (Dobbing, 1964). In tra u te r in e  undernutrition resu lts  in 
d e f ic ie n t  amount of cerebroside sulphatide in the combined brain stem 
and cerebrum of SFD babies (Chase,, e t  a l . ,  1972). I t  is also fu r th e r  
suggested th a t  the cerebroside sulphatide is  reduced in ch ro n ica lly  
malnourished children when compared with normal children of the same 
age (Chase, e t  a l . , 1974). However, th is  and other studies (Rosso, e t  a l . ,  
1970) ind ica te  th a t  the brains of postnata lly  malnourished children  
contain too l i t t l e  myelin fo r  th e i r  age, there is no evidence tha t  the  
deposition of myelin is affected p r e fe r e n t ia l ly .  In f a c t ,  the cholesterol  
content of the brain of severely malnourished children has been found to  
be appropriate fo r  the weight of the brain (Dickerson, 1975).
Myelin undergoes a developmental process with age and there is  
evidence th a t  in the ra t  th is  process is retarded by m alnu tr it ion  from 
an ea r ly  age (Yusuf & Dickerson, 1979). I t  may be th a t  the high concentra­
t ion  of cholesterol esters in the brain of malnourished children also  
indicates a re tardation  of myelin development.
1 . 1 . 5 .  The e f fe c t  of m a ln u tritio n  on d e n d ritic  growth
Yusuf, e t  al;. ,(1977) showed th a t 'a  d is ia loganglios ide  (GDia) is  
the major constituent of the to ta l  gangliosides in the cerebrum of human 
bra in . I t  has also been thought th a t  the e levation of cerebral GDia 
indicated an increase in d en d r it ic  arborization  and neuronal in te r ­
connections in the t issue (Yusuf & Dickerson, 1978).
These workers reported tha t  the content of ganglioside NeuNAC in the 
forebra in  of malnourished children were lower than would have been 
expected from the reduced brain weight. I t  thus appears tha t d en d r it ic  
growth is more susceptible to m alnutrit ion  from an ea r ly  age than is
e ith e r  c e l l  m u lt ip l ic a t io n  or m yelination.
1.2 N u tr i t io n  and brain metabolism-
The brain has a high oxygen and energy requirement. Glucose is  
the preferred energy source fo r  the b ra in , but when the supply of glucose 
f a l l s ,  as a re s u lt  of s ta rva t io n , the brain adapts i ts  metabolism to  
u t i l i s e  endogeneous protein in addition to ketone bodies (Owen, e t ’ a l . ,  
1957). There is ,  however, a rea l dependence on the supply of oxygen, 
and anoxia may cause i r re v e rs ib le  brain damage. Moreover, one con- . 
sequence of the high energy requirement of the brain is tha t  i ts
metabolism is sens it ive  to de fic ienc ies  of vitamins and p a r t ic u la r ly
those of the B group which function as coenzymes in intermediary  
metabolism. Vitamins A, D, E and ascorbic acid have in d ire c t  or lesser  
e f fe c ts .  Furthermore, a constant supply of essential n u tr ie n ts ,  inc lud ­
ing amino acids as precursors of e i th e r  prote in  or neurotransm itters,  
are required fo r  normal brain function .
1 . 2 . 1 .  P rotein-energy In take
The re la tionsh ips  of d ie ta ry  protein and energy to the metabolism 
in the brain are of importance in children suffering  from PEM. The 
concentrations of serum protein  and most of the amino acids, esp ec ia lly  
the essentia l ones, f a l l  (M ilne, 1968). The formation o f prote in  in 
the cerebellum was reduced p a r t ic u la r ly  by postnatal m alnutr it ion  (Chase,
1976). Furthermore, the concentrations of dopamine and vanilmandelic  
acid (VMA), the major m etabolite of noradrenaline, were depressed in 
the urine of ch ildren suffering  from kwashiorkor. However, these 
compounds were found to r is e  during the course of n u tr i t io n a l  therapy  
(Hoe1dtke& Wurtman, 1973).
In mice maternal undernutrition during gestation and la c ta t io n ,  
followed by r e h a b i l i ta t io n  from weaning, resulted in complete absence of 
the S-100 protein  in the brain of the adult animals. (Lee, 1973).
Moreover, Dickerson and Pao (1975a) found th a t  prenatal and postnatal
1 h
maternal m alnutrit ion  in ra ts  depressed the uptake of C -glucose in 
the forebra in  and cerebellum of progeny. Thus, n u tr i t io n a l  d e fic ienc ies  
e a r ly  in l i f e  may have a profound e f fe c t  on the protein content and 
supply of glucose of the mature brain and d i f fe r e n t  parts of the brain  
may be affected to a d i f fe r e n t  extent.
Some amino acids are p a r t ly  synthesised lo c a l ly  in the b ra in ,  w h ils t  
the entry of others is  contro lled  by uptake, extrusion and exchange 
(Baxter, 1968). Some of the amino acids in the brain may function as 
neurotransmitters or as precursors fo r  such compounds. Rajalaksmi, e t  al-.-, 
(1967) reported tha t  in r a t  l i t t e r s  undernourished during the suckling  
period, the concentrations of GABA, glutamic acid, glutamine, aspartic  acid 
and alanine in the cerebrum were not changed at weaning. On the other hand,
in the o ffspring  of p ro te in -d e f ic ie n t  ra ts ,  the concentration ,of aspartic  
acid was increased in the forebra in  and cerebellum (Dickerson & Pao, 1975a). 
Furthermore, Kaladhar and Narasinga Rao (1977) reported th a t  in severe 
energy r e s t r ic t io n  the f re e  amino acid composition of the brain was not 
modified, whereas in prote in  defic iency certa in  amino acids were affected  
in the brain of ra ts .  I t  thus appears th a t  the protein  content of the  
d ie t ,  duration and s ev er ity  of the m a ln u tr it io n , and age o f animals are 
fac tors  th a t  a l t e r  the concentration of certa in  amino acids in the bra in .
The e f fe c t  of low protein  d ie t  on brain tryptophan and on serotonin  
turnover is of in te re s t  in re la t io n  to brain fu n c t io n .,  Dickerson and Pao,
(1975^) reported th a t  feeding a 3% casein d ie t  to weanling ra ts  fo r  56 
days reduced the plasma and brain levels  of tryptophan. The uptake of  
tryptophan into the brain was also reduced and the concentrations of 
serotonin and i t s  m etabolite , 5-hydroxyindole-acetic acid (5-HIAA) 
were lower than in normal ra ts .  In contrast with the previous studies,  
Fernstrom, e t  a ! .., (1973) reported th a t  when adult ra ts  th a t  had been 
fasted overnight were given access to d iets  containing 18% casein, or 
a synthetic amino acids mixture s im ila r  in composition to 18% casein 
(Fernstrom & Wurtman, 1972a), the plasma tryptophan was increased but 
not the brain tryptophan nor serotonin. The consumption of high prote in  
d ie ts  has also been reported to e levate  brain tyrosine (Gibson & Wurtman,
1 9 7 7 ) . '  However, when the fasted ra ts  received in su lin  in je c t io n  
(2U/kg. i . p . )  (Fernstrom & Wurtman, 1972^), or were given access to a 
carbohydrate d ie t  (Fernstrom & Wurtman, 197Ta), the increase in plasma 
tryptophan was followed by the e levation  of. tryptophan and serotonin  
levels  in the b ra in .  ■
- 1 . 2 . 2 .  .Vitamins in take
The a v a i l a b i l i t y  o f  vitamins, p a r t ic u la r ly  those which e x is t  
la rg e ly  as coenzymes, is of importance fo r  the functioning of the b ra in .
(a) Thiamine (Bx)
The u t i l is a t io n  of thiamine as i t s  pyrophosphate (TPP) in carbo­
hydrate metabolism was shown in th iam in e -d e fic ien t  animals in which the 
concentration o f  TPP was diminished (Wolstenholme & 0 / Connor, 1967), and 
acety lcho line synthesis was supressed (Bhagat & Lockett, 1962).
( b )  N ico tin ic  acid ( B 3 )
The n ic o t in ic  acid d e r iv a t iv e s , nicotinamide adenine dinucleotides  
(NAD+ and NADP+) are important by v ir tu e  of th e i r  p a r t ic ip a t io n  in 
cerebral g lyco lys is . Thus, impaired glucose metabolism in pe llag ra  
(Bedi, e t  a l . ,  1977) may be secondarily responsible fo r  the neuro­
log ica l m anifestations. The metabolic re la tionsh ips  between n ic o t in ic  
acid , tryptophan and pyridoxine (Oghuri, 1974) in neurological function  
may be in th e i r  involvements through several steps in the kynurenine 
pathway (Dickerson & W iryanti,  1978).
(c) Pyridoxine (B6)
Pyridoxine is involved in  amino acid metabolism as a co -fa c to r  of  
aminotransferases. Pyridoxal phosphate (PPi) is  also involved in  
decarboxylation o f 5-HTP to form serotonin (Weissbach, et a l . ;  1959). 
Moreover, Roberts, e t  a l . , (1951) found th a t  in p y r id o x in e -d e f ic ie n t  
ra ts ,  the formation of. GABA was depressed. This condition was, however, 
recovered by adm inistration of the vitam in.
(d) Cobalamines (B12)
The adenosine d er iva tives  of cobalamines play a ro le  in the 
isomerisation of methyl-m.alonyl-CoA to succinyl-CoA in l ip id  metabolism 
(Mcllwain & Bachelard, 1971). This may be important in the myelination  
processes in the b ra in .
(e) Pantothenic acid (B„)
Most of the pantothenic acid in the brain ex is ts  in  a combined 
form which has a property s im ila r  to th a t  of acetyl-CoA in brain  
acety lcho line synthesis.
( f )  R iboflav in  (B2)
About a f i f t h  of the r ib o f la v in  present in the brain occurs as 
mononucleotide (Lowry, 1952) which functions in the resp ira tory -cha in  
and in amino acids metabolism. Kusuya and Nagatzu (1959) indicated  
tha t the flavin-coenzyme may be involved in the cerebral MAO reac tion .
Vitamins A, D, E and others are considered to have an in d ire c t  
e f fe c t  in the functioning of the b ra in .
1.3 N u tr it io n  and, brain function
I t  has been suggested th a t  a neuronal d e f i c i t  in undernourished 
animals is  a fa c to r  in causing behaviour changes (Stewart, 1974).
Children su ffer ing  from kwashiorkor have been reported to become anorexic.  
This condition is usual1y’ accompanied by mental apathy and i r r i t a b i l i t y .  
(CIBA Foundation Symposium, 1972). I t  may also be induced when one of 
the essential amino acids is  omitted from the d ie t  (M ilne, 1968).
The self-imposed re s t r ic t io n  of food intake c h a ra c te r is t ic  o f .  
anorexia nervosa has been considered to be due to the consumption of a 
d ie t  severely depleted in carbohydrate but r e la t iv e ly  high in p ro te in .
I t  was found, however, th a t  plasma proteins and amino acids in these 
patients  remained w ith in  the normal range, in sp ite  of the decrease in 
body weight.
The n u tr i t io n a l  involvement in some mental diseases may be due to 
an ia trogenic  e f fe c t  of drugs. Thus, anti-convulsant drugs may a l te r  
the metabolism of Vitamin D (Stamp, e t  a l . ,  1972), or induce f o l i c  acid 
defic iency (Reynold, 1973) in e p i le p t ic  pa t ien ts . The depression found 
in some women taking oral contraceptives (Herzeberg, et a l . , 1970)may be due 
to a defic iency in pyridoxine (Adams, et a l . ,  1973). Moreover, the
s e n s i t iv i ty  of the brain to general metabolic impairment may be due to  
inherited  metabolic disorders (Cumings, 1972) which resu lts  in mental 
disturbance or re tardation  (S tern , 1974).
Disturbances" in the metabolism of tryptophan are features o f psychi­
a t r ic  disorders. A defect in serotonin synthesis (Lapin & Oxenkrug, 1969) 
was found in patients  suffering  from p e llag ra , Huntington's chorea, 
depression and possibly with schizophrenia. Osmond and Smythies (1952) 
also suggested th a t  schizophrenia is the outcome of stress-induced anxiety.  
I t  may be a f a i lu r e  of metabolising adrenaline which resu lts  in the  
production of a tox ic  compound, fo r  example, 3 , 4-dimethoxyphenylalanine  
(DMPEA), (Harley-M.ason, 1952). A l te rn a t iv e ly ,  a psycho-toxic oxidation  
product of adrenaline, adrenochrome, may be responsible fo r  the psycho- 
pathological changes.
Therefore, the central noradrenergic neurone is important in the  
control o f  emotional s ta te ,  v
2. THE ROLE OF MONOAMINES IN NEUROTRANSMISSION
The function  of biogenic amines as chemical transm itters  in 
the CNS involves a mechanism th a t  regulates th e i r  synthesis and 
storage in the presynaptic neurones. When there is an e le c t r ic a l  
stim ulation  of these neurones the stored tra n sm itte r  is released  
in to  the synaptic c l e f t  and in te ra c ts  postsynaptica lly  with a receptor  
on the membrane causing transmission of the impulse to the postsynapti 
neurone. A f te r  crossing the synaptic c l e f t  -and ac t iva t in g  the post- 
synaptic neurone, the tran sm itte r  can e ith e r  be taken up by the 
postsynapse or by an adjacent g l ia l  c e l l  and converted to an in ac t ive  
form or i t  can be taken up again by the presynaptic mechanism. Post- 
synaptic catabolism varies according to the chemical tran sm itte r  
involved. The processes involved in the synthesis and breakdown of 
neurotransmitters are influenced by enzymes at d i f fe r e n t  s ites  and 
these, in tu rn , are influenced by hormones, drugs and environmental 
s t im u li .  The mechanism of the chemical transmission in the CNS is  
shown in F ig . 1.3 .
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Fig. 1 .3 . Chemical transmission in the CNS (Bender, 1975).
2.1 Factors in regu la tion  of the central synapse in monoaminergic system
The concept of 'turnover1 of neuronal catecholamines and serotonin  
involves the processes of synthesis, storage, re lease , re-uptake and 
degradation in the central monoaminergic synapse. Various fac tors  play  
important roles in the regulation  of these processes. Thus, they are 
regulated by the level of substrate in nerve endings, the amount and 
a c t iv i t y  of l im it in g  enzymes in the c e l l  bodies and in nerve endings, and 
a p o te n t ia l ly  regu latab le  parasynaptic in ac t iv a tio n  process. This l a t t e r  
process y ie ld s  terminal metabolites which are then excreted, i n i t i a l l y  
into the cerebrospinal f lu id  (CSF) and u lt im a te ly  in the urine.
2 .1 .1 .  Synthesis and storage of monoamines in neurones
The neuronal synthesis of serotonin and of dopamine and noradrenaline  
requires a continuing external source of tryptophan and ty ros ine , respect­
iv e ly ,  which is provided by the blood and the e x tra c e l lu la r  f lu id  of the 
brain (Wurtman & Fernstrom, 1972 ) .
The physiological mechanism by which the flow of the nerve impulse 
regulates monoamine synthesis is by a l te ra t io n  in the k in e t ic  properties  
of the l im it in g  enzymes, tryptophan hydroxylase (Hamon&.Glowinski, 1975), 
and tyrosine hydroxylase (Weiner, 1970). Wei.ner (1970) and G low inskiaU l972)  
using in V itro  methods, showed that the regulatory  process at the hydroxy- 
la t io n  step of synthesis is ,  in a l l  cases, contro lled  by a negative feed­
back mechanism acting by end-product in h ib i t io n .
The subsequent decarboxylation step by which L-HTP and L-DOPA (L -3 ,
4-dihydroxyphenylalanine) are converted in to  serotonin and catecholamine 
resp ec tive ly , takes place w ith in  the s e r o t o n e r g ic  and catecholaminergic  
neurones.
There is evidence tha t most of the newly-formed transm itters  are 
stored in a bound-form in synaptic vesicles (Tamir & Gershon, 1979) are 
used fo r  extraneuronal re lease , while those in the free-form  may act as 
a reserve pool in the synaptosomal cytoplasm (Bachelard, 1974).
Hamon, e t  a l . ,  (1974) indicated th a t  increase in the extraves icu la r  
serotonin resulted in an increased product-ifeedback in h ib it io n  and 
subsequently a reduction in the conversion of tryptophan to serotonin.  
Thus, th is  may suggest tha t release and re-uptake of transm itters  by 
nerve endings are other factors  with a secondary ro le  in the regu la tion  
of biosynthesis w ith in  the synaptic apparatus (Mandell, e t  a l . ,  1974).
2 .1 .2 .  Release and re-uptake o f transm itters
There are three suggested ways in which the transm itte r  is  released  
into the synaptic c le f t  from the synaptic vesicles (Bachelard, 1974). 
These are: 1) th a t  the whole ves ic le  passes into the c l e f t  and d is in te ­
grates, thus discharging i ts  contents, 2) th a t  the v e s ic le ,  on coming 
in to  contact with the presynaptic membrane, opens up into a pore in the  
membrane through which the tran sm itte r  passes ( i . e .  'exo cy to s is ') ;
3) tha t  the stimulus causes the synaptic ves ic le  to discharge i t s  
contents into  the nerve-ending in the immediate v ic in i t y  of the pre­
synaptic membrane and the transm itte r  d iffuses through th a t  membrane. 
There is  some morphological and histochemical evidence in support of 
'exocytosis* of noradrenaline vesicles (Smith & Winkler, 1972).
The tra n sm itte r  th a t  has been released can be retaken-up by e i th e r  
the autoreceptor in the presynaptic neurone and stored in vesic les  
together with the newly-synthesised amines, or by the postsynaptic neurone 
where i t  is  degraded by mitochondrial MAO. The uptake of serotonin and 
of catecholamines takes place by means of an active  pump mechanism in 
the neuronal membrane (Dahlstrdm, 1973; F u l le r  & Wong, 1977). Bender 
(1975) indicated th a t  th is  pump-mechanism can be activated in v i t r o  by
t r i c y c l i c  antidepressant agents, (e .g .  imipramine, chlorimipramine and 
a m itr ip ty l in e )  which then enhance the a v a i l a b i l i t y  of the transm itte r  
amines in tran eurona lly .  On the contrary, other workers (Carlsson, 1970; 
Shaskan & Snyder, 1970) found th a t  the uptake of serotonin in to  the brain  
slices is blocked by the t r i c y c l i c  compounds. Moreover, Brimblecombe (1974) 
indicated tha t the primary action of these drugs is  to in h ib i t  MAO at the 
postsynapse and there fore  prevent the breakdown of amines at receptor s i te s .  
However, in sp ite  of these contradictory  f ind ings , i t  is generally  believed  
tha t  many forms of psychological depression are associated with a defect in 
amine metabolism -  th a t  the amines may be produced or released in inadequate 
quantit ies  or destroyed too rap id ly  (Brimblecombe, 1974).
I t  has also been suggested th a t  the t r i c y c l i c  agents may cause a
reduction in serotonin turnover by means of feedback in h ib it io n  of
*
serotonin neurones (Corrodi & Fuxe, 1969) which therefore  in h ib i t  the 
neuronal f i r in g  system of serotonin (Sheard, e t  a ! . . , 1972, Bramwell, 1974). 
These suggestions have led to speculation th a t  increased serotonin at  
postsynaptic s i te s ,  an e levation  in -presynaptic  concentration of serotonin, 
or serotonin uptake-blockers or MAO in h ib ito rs  could depress serotonin c e l l -  
f i r in g  d ir e c t ly  (Aghajanian & Wang, 1978). Consistent with th is  view is 
the fa c t  th a t  the L-tryptophan and 5-HTP applied lo c a l ly  by microiontophores 
re a d i ly  depresses the f i r i n g  of serotonin c e l ls  a f te r  they are converted 
to serotonin (Gallagher & Aghajanian, 1976).
2 .1 .3 .  Degradation of the amines by postsynaptic neurones
Serotonin and the catecholamines, dopamine and noradrenaline, in te ra c t  
pos t-synap tica lly  with a receptor on the membrane and are degraded by MAO 
and catecholamine 0-methyl transferase (COMT). There are some suggestions 
(Saavedra, e t  a l . ,  1973; Banerjee & Snyder, 1973) tha t  N-methylation of  
serotonin can be carried  out by the brain enzymes using S-adenosylmethionine
or N -5 -m ethy l-te trahydro fo lic  acid (5-MTHF) as the methyl-donor. This 
enzymatic process is an in ac t iv a tin g  one, comparable to O-methylation in 
the catecholamines systems. There is a suggestion tha t  alkylamine-N- 
methyltransferase (.AANMT) may be a regulatab le  fa c to r  re la ted  to the 
removal of serotonin from the receptor v ia  N-methylation (Trendelenberg, 
et a l . ,  1971).
2 .2 .  Control of enzyme a c t iv i t y  mechanisms
The synthesis of the tra n sm itte r  and the a c t iv i t y  of r a te - l im i t in g  
enzymes are in tegrated and contro lled  by both neuronal and humoral systems. 
Trans-synaptic induction, as well as the physical properties of the enzymes 
are of importance in determining th e i r  k in e t ic  properties .
2 .2 .1 .  Trans-synaptic enzyme induction
Trans-synaptic enzyme induction in nerve c e l ls  is mainly concerned
*
with enzymes involved in tra n sm itte r  metabolism or function . These are 
inducible by a number of factors  including neuronal impulse f low , drugs, 
hormones and environmental cond it ions ..
The enzymes are thought to be synthesised in the neuronal c e l l  body 
and transported to th e i r  functional s i te  in the nerve ending by the neurone- 
axonal f low . The induction of tyrosine-hydroxylase by increased impulse 
flow through presynaptic cho linerg ic  f ib re s  has been examined in adrenergic  
neurones of ganglia from the sympathetic nervous system (Axelrod, 1971). 
Thoenen (1972) suggested tha t  reserpine or 6-hydroxydopamine induce the  
a c t iv i t y  of tyrosine hydroxylase by promoting the release o f noradrenaline  
from storage s i te s .  Furthermore, the increase in tyrosine hydroxylase 
a c t iv i t y  is prevented by cycloheximide, a protein-synthesis in h ib ito r ,  and 
by actinomycin (M ue lle r , e t  a l . ,  1969a), which in te r fe re s  with the formation  
of messenger RNA. I t  has been shown th a t  the r is e  in enzyme a c t i v i t y  is
the re s u lt  of an increase in i t s  de novo synthesis (Hoeldtke, e t  a l . ,  1974).
Lowering the environmental temperature to 4°C fo r  one hour or swimming 
stress (G uidotti  e t  al.. ,  1973) is associated with increased adrenergic 
a c t iv i t y  and also resu lts  in increased enzyme a c t iv i t y  (M eu lle r , e t  a l . ,  1969b).
Cyclic nucleotides seem to be involved in tyrosine hydroxylase induction  
(G u id o tt i ,  e t  al-.-, 1975) in adrenergic neurones and cerv ica l ganglia
(Mackay & Iversen, 1972). Thus, an increase in cAMP, with a decrease in
cGMP occurs a f te r  adm inistration of inducers and is fo llowed by an increase
in tyrosine hydroxylase a c t iv i t y  (Guidotti & Costa, 1973).
Other fac tors  are also involved in enzyme induction, such as c o r t ic o ­
steroids which influence the superior cerv ica l ganglion (G u id o tt i ,  e t  a l . ,
1975) and the adrenal medulla (Goodman, e t  a l . ,  1975). Azniitia and McEwen, 
(1959) reported th a t  lower leve ls  of tryptophan hydroxylase occurring in 
the midbrain fo llow ing adrenalectomy could be restored by adm inistration  
of corticosterone. Further studies (Azm itia , e t  al..., 1970) showed tha t  
the conversion of tryptophan to serotonin was reduced in adrenalectomised 
animals.
2 .2 .2 .  The physical s ta te  of the enzymes
I t  has been suggested that the hydroxylase-enzymes e x is t  in two 
d is t in c t  forms, one soluble and the other bound to p a r t ic u la te  or membrane 
fra c tio n s  (Knapp & Mandell, 1973). Tyrosine-hydroxylase is la rg e ly  present 
in the cytoplasm of catecholaminergic neurones, but a certa in  proportion  
is  found in the fra c tio n s  containing the synaptosomes (Musacchio, e t  a l ..,
1973) o f  b r a i n  areas r ich  in nerve terminals (Kuczenski & Mandell, 1972). 
Tryptophan-hydroxylase also appears to be in a soluble form in the brain  
(Robinson, et a ! . ,  1958). However, a var iab le  proportion of i t  is  also 
found in p a r t ic u la te  fra c tio n s  from d i f fe r e n t  brain regions according to
the concentration of serotonergic nerve endings (Knapp & Mandell, 1973).
As in the case of tyrosine-hydroxylase (Kuczenski & Mandell, 1972), the 
neuronal membrane-bound tryptophan hydroxylase exh ib its  an e n t i r e ly  d i f f e r ­
ent set of k in e t ic  properties from  bound to other membranes or from tha t  
of the soluble enzyme (Kuczenski, 1973). I t  has been proposed (Kuczenski,
1973) th a t  the properties of tyrosine hydroxylase are a lte red  when the  
enzyme is bound to c e l l  membranes, and th a t  these changes can p a r t ly  be 
mimicked by the addition of a negative ly  charged molecule, such as heparin, 
to the soluble enzyme. .
2 .2 .3 .  Factors influencing the amount and a c t iv i t y  o f the ra te -  
l im it in g  enzymes.
Both tyros ine  and tryptophan hydroxylase have been shown to fo llow  
Michaelis-Menton k in e t ic s  with respect to th e i r  substrates, oxygen and 
reduced p terine  cofactor ( Ikeda, e t  a l . ,  1966) during the biosynthesis  
of monoamines neurotransm itter. Other factors  tha t regulate hydroxylase 
a c t iv i t y ,  in v iv o , are the conformational change in the enzyme p ro te in ,  
the presence of product feedback in h ib i t io n ,  and the concept of 'receptor-  
mediated feedback in h ib it io n '  (Lovenberg & V ic to r ,  1974). These workers 
indicated tha t  acute regulation of hydroxylase a c t iv i t y  appears to be by 
substrate a v a i l a b i l i t y  in the case o f tryptophan hydroxylase, and possibly  
by feedback in h ib it io n  in the case o f  tyrosine hydroxylase. The a c t iv i t y  
is also a ffected  by the ionic environment of the active  s i te  of the hydroxy­
lase enzymes (Udenfriend, 1966).
(a) Concentrations of substrate and oxygen
s’
I t  has been suggested th a t  the levels  of tyrosine and oxygen are 
saturating fo r  the tyrosine hydroxylase system (Shuman, e t  a l . ,  1971),  
whereas the tryptophan levels  are thought to be below th a t  required fo r
optimal a c t iv i t y  (Friedman, e t  a l . ,  1972). Further studies, in v i t r o , 
showed th a t  the substrate in h ib it io n  at leve ls  about twice the Km occurs 
with both enzymes, when tetrahydrob iopterin  (BH«0 is used as a cofactor.
The oxygen concentration, in v ivo , has been shown to ra p id ly  influence  
the ra te  of noradrenaline and serotonin synthesis (D iaz, et. a ! .., 1968 ;
Knapp & Mandell; 1972) fo llow ing decarboxylase in h ib it io n  as an index of  
tyros ine  and tryptophan hydroxylase a c t iv i t y  (Carlsson, e t  a l . , 1972).
Both DOPA and 5-HTP were found (Davis & Carlsson, 1973) to vary in 
response to the percentage of oxygen in a i r  breathed by the animals. These 
observations, thus, suggest th a t  hypoxia may reduce tyrosine and tryptophan 
hydroxylation by a d ire c t  e f fe c t  on the a v a i l a b i l i t y  of oxygen to the enzymes.
(b) Concentration of cofactor *
Another possible means of regulating the hydroxylase enzymes is by 
a lte ra t io n s  of leve ls  of reduced p ter in e  cofactor. BH^ . (Friedman, e t  a l . ,
1972) is  considered, in v ivo , to .be the natural cofactor fo r  both tyros ine  
and tryptophan hydroxylase (Kaufman, 1974). I t  has been suggested th a t  the  
concentration of B N i n  tissues may play a regu latory  ro le  in determining  
the rates of hydroxylase-enzyme a c t iv i t y  (Kaufman, 1973; Lovenberg & V ic to r ,
1974). Levine, e t  al..., (1979) reported the presence of high concentrations  
of hydroxylase cofactor in brain areas found to contain large amounts of  
ty ro s in e -(s tr ia tu m ) and tryptophan- (mesencephalic tegmentum) hydroxylase 
a c t iv i t y .  However, these workers have also reported th a t  large q u a n tit ies  
o f  hydroxylase cofactor in other areas involved in neuroendocrine function  
(hypothalamus, pineal gland and p i tu i t a r y  gland) in which there is  r e la t i v e ly  
l i t t l e  hydroxylase a c t iv i t y .  Thus, i t  seems th a t  th is  reduced p te r in e  co- 
fa c to r  could have a ro le  in neuroendocrine function , apart from serving as 
an electron donor fo r  hydroxylation.
L-Tyrosine L-DOPA
OR
C H a - C - C O O H
A
L-Tryptophan
HO
L-HTP
NH=
C H a - C - C O O H .
H
Hydroxylase
Jetrahydropteridiine
TPN+
Reductase
Dehydropteridine 
(qu ino id )
T P N H
TPN+: triphosphopyridine  
nucleotide
TPNH: reduced TPN
Fig. 1.4 Scheme of the reaction mechanism of hydroxylation of L -ty ros ine  
on L-tryptophan. (Lovenberg & V ic to r ,  1974).
In current studies BH^  may be replaced as cofactor fo r  hydroxylation
reactions by e i th e r  6-MPH* (2-amino-4-hydroxy-6-m ethyltetrahydropterin)
(Kaufman, 1973)» or DMPH,, (2-am ino-3-hydroxy-6 ,7-d im ethyltetrahydropterin )
(Gal & Patterson, 1973). However, i t  is  usually claimed tha t  BH„ and
6-MPH„ are more ac tive  cofactors than is DMPH*. This may, thus, show that
not only the concentration but also the nature of cofactors plays a ro le  in 
regulating hydroxylation.
(c) Concentration o f enzyme protein
The homeostasis of the amine system can be disturbed by drugs l ik e  
reserpine by tem porarily  increasing the cytoplasmic concentrations o f amines 
fo r  competition with the cofactor (A b ita , et a l . ,  1976). The competition  
is  reduced a f te r  a longer period by depleting stores (Kuczenski &
Mandell, 1972) and leads over the long-term to a compensatory increase in
the amount of enzyme prote in  a va ilab le  fo r  use in synthesis of the neuro­
tra n sm itte r  (Segal, e t  a l ,. ,  1971). Decrease in b iosynthetic  enzymes can be 
induced by regu lar treatment with t r i c y c l i c  compounds (Mandell, et. a l . ,
1975). Joh, e t  a l . ,  (1973) indicated tha t  such increases or decreases in  
enzyme prote in  f i r s t  appear in c e l l  body regions of the brain and are 
carried  by energised waves of m icrotubular prote in  down axonal sluices  
and remain at a new level in the nerve ending fo r  a few days or weeks.
(d) Product- and receptor-mediated feedback in h ib it io n
I t  has been shown, in v iv o , (Spector, e t  a l . ,  1967) th a t  an increase  
in the level of noradrenaline by MAO in h ib it io n  is associated with decreased 
synthesis of lhC noradrenaline from tyrosine in the b ra in . S im i la r ly ,  
Macon, e t  a l . ,  (1971) have reported decreased [ 3H] serotonin synthesis from 
[ 3H] tryptophan by MAO in h ib it io n  or addition of serotonin. On the other  
hand Jequier, e t  a ! . ,  (1969) have indicated th a t  in contrast to catechol­
amines which in h ib i t  the a c t iv i t y  of soluble tyrosine hydroxylase, serotonin  
has no e f fe c t  on the a c t iv i t y  o f  soluble tryptophan hydroxylase. This may 
no longer support the hypothesis of in vivo end-product regu la tion  of 
serotonin synthesis. However, th is  notion has been disputed, as i t  has 
been shown, in v i t r o , th a t  brain s lices  from animals pretreated w ith MAO 
in h ib ito rs  (Hamon, e t  a1. ,  1-973) have a reduced ra te  of 5-HTP formation when 
intraneuronal stores of serotonin are elevated. This conclusion has been 
supported by the fa c t  th a t  a decrease in the ra te  of 5-HTP accumulation 
in the brains of mice a f te r  in je c t io n  with MAO in h ib ito rs  follows the  
blockage o f 5-hydroxytryptophan decarboxylase (Carlsson & L indqvis t, 1972).  
This may lead to a suggestion tha t  the end-product regu la tion  of serotonin  
synthesis resu lts  from the in te rru p tio n  of nerve impulses on the seroton-. 
ergic neurone. This in h ib it io n  by a so-called  'receptor-mediated feedback 
regu la tio n '1 has also been shown in ra t  striatum  (Carlsson, e t  a l ;/, 1973) 
in which an increase in dopamine synthesis fo llow s a decrease in dopamine 
receptor a c t iv i t y  resu lt in g  from the in te rru p tio n  of dopamine re lease  
fo llow ing destruction of dopaminergic axons.
(e) Ion ic  environment
The hydroxylation reaction has an absolute requirement fo r  p te r in e -
cofactor which is stimulated by pyrid ine nucleotide and cata lase . There
++
is  considerable evidence .that Fe ions also stim ulate the reaction
(H o r i,  et a l . ,  1976; Hamon, e t  a l . , 1978) in the absence of catalase
++(Friedman, e t  a l . ,  1972). This may suggest th a t  catalase or Fe protects
a sen s it ive  component of the hydroxylase system from in a c t iv a t io n .  Ionised  
++
calcium (Ca ) has also been shown to a c t iva te  tryptophan-hydroxylase
(Knapp, e t  al..., 1975) and tyrosine-hydroxylase in reasonable concentration
(Morgenroth I I I ,  e t  al..., 1974). The ac t iva t io n  of hydroxylase systems by
Ca++ has been suggested to be due to increased a f f i n i t y  of enzyme f o r  both
substrate and cofactor (Knapp, e t  a l . ,  1975). Activation  of tryptophan  
++
hydroxylase by Ca may involve p a r t ia l  proteolysis  (Hamon & Bourgoin, 1979), 
and the removal of a peptide fragment from the enzyme i t s e l f  (Hamon, e t  a l . ,  
1978) or possibly d ire c t  ac t iva t io n  (Hamon, e t  a l . ,  1977). Other studies  
(Hamon, et al..-, 1977; Boadle-Biber, 1978) also showed th a t  the e f fe c t  of  
Ca is  i r r e v e r s ib le ,  there fo re  unrelated to the f lu c tu a t io n s  in tryptophan 
hydroxylase a c t i v i t y .  I t  may be dependent upon the changes in the flow of  
the nerve impulse in the s e r o t o n e r g ic  neurones (Herr & Roth, 1976). Since 
Ca ions are known to be essentia l fo r  the ac t iva t io n  of brain adenyl- . 
cyclase (Bradham, et a ! .., 1973) and fo r  the a v a i l a b i l i t y  of membrane-calcium, 
i t  could be expected th a t  Ca++ may enhance cyc lic  AMP form ation. Roth, e t  a l . 
(1975) have suggested th a t  the control of catecholamine synthesis may also 
be regulated by Ca and th a t  c yc lic  AMP may be linked to nervous a c t i v i t y .
+ +  *H *
Other m e ta l l ic  cations, such as magnesium (Mg ) ,  lanthanum (La ) ,
4-+ ++ ++ ++
n ick le  (Ni ) ,  cobalt (Co ) ,  barium (Ba ) and manganese (Mn ) have a 
depressant action on the neurones in the CNS by supressing the f i r i n g  
frequency of neurones ( P h i l l i s ,  e t  a l .., 1973). Additional evidence
(M i le d i ,  1971) indicated th a t  the e f fe c t  of magnesium may be to supress 
the presynaptic release of the tra n sm itte r .
2 .3  Involvements of cAMP and cGMP by nucleotide-cylases in neurotransmission.
Cyclic AMP acts not-only  as a second messenger fo r  most hormones but 
also, together with the other natural cyc lic  nucleotides, cGMP (Weight, e t  a l .., 
1974; Ferrendelli ,e ta l,: 1975) appears to be involved in the control of almost 
a l l  c e l lu la r  a c t i v i t y ,  including metabolic processes in CNS and p a r t ic u la r ly  
the mediation o f  the action o f some neurotransmitters a t  ce rta in  type of  
synapses (Robinson, e t  a l . . ,. 1971; Greengard, 1975).
Adenyl-cyclase,which controls the ra te  o f synthesis o f cAMP from ATP,
++
is  a membrane-bound enzyme th a t  requires Mg fo r  a c t iv i t y  and is  stimulated
by a large v a r ie ty  o f  hormones. Guanyl-cyclase, the enzyme co n tro l l in g  the
synthesis of cGMP from GTP, resembles adenyl-cyclase. This l a t t e r  enzyme
is found in both the p a r t ic u la te  and soluble fra c tio n s  of c e l ls  (Goridis
& Morgan, 1973) and appears to be e n t i re ly  dependent on the presence of 
++
Mn . Krishna, et a l .., (1972) indicated tha t  adenyl-cyclase and guanyl- 
cyclase may in te ra c t  in two ways. F i r s t l y ,  GTP, as substrate o f  guanyl- 
cyclase, is a cofactor fo r  the a c t iv i t y  of adenyl-cyclase in some systems 
and secondly, Ca increases the a c t iv i t y  of adenyl-cyclase and, at the same 
t ime, in h ib its  the a c t iv i t y  of guanyl-cyclase.
Certain neurotransmitters can stim ulate the biosynthesis o f  cAMP and 
cGMP in postsynaptic neurones (Greengard, 1975). These nucleotides regu la te  
several metabolic processes, including protein  synthesis and possib ly by 
modulating the a c t iv i t y  o f adenyl- and guanyl-cyclase to regu la te  the  
synthesis o f inducible  enzymes in the neurones. Goldberg, e t  a l . , (1 9 7 3 )  
have suggested th a t  cAMP and cGMP may function as an e f fe c to r  th a t  promotes 
trans-synaptic  induction of enzyme pro te in . Costa, e t  a l .., (1974) 
supported the view th a t  some influences in postsynaptic neurones can be
mediated by the release of tra n sm itte r  and im plicate  an involvement of 
c y c lic  nucleotide as the promoters of the induction of hydroxylase-enzymes. 
In add it ion , l ik e  cAMP, the e f fe c ts  of cGMP seems to depend upon the action  
of p ro te in -k inase  (L o l le y  & Farber, 1977). The mechanism o f the ac t iva t io n  
of cGMP-dependent p ro te in -k inases, th ere fo re , appears to be analogous to 
th a t  by which cAMP brings about the ac t iva t io n  of cAMP-dependent p ro te in -  
kinases. ( F i g . 1 .5 ) .
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F i g . 1.5. Model of the proposed mechanism by which cAMP may mediate
synaptic transmission at ce rta in  types o f synapses (Greengard, 1975).
3. BIOCHEMICAL AND PHARMACOLOGICAL FUNCTIONS OF PUTATIVE NEUROTRANSMITTERS
The monoamines and certa in  other ami noacids appear to have poten tia l  
pharmacological a c t iv i t y  consistent with a neurotransmitter function in 
the brain (Curzon, 1972). Dopamine and noradrenaline is  synthesised from 
L-tyrosine and serotonin from L-tryptophan.. Other aminoacids, such as 
asparta te , glutamate and GABA (x -  aminobutyrate), are involved in metabolic  
processes in the brain (Neame, 1968), while glycine (B e r l ,  e t  al., 1975) 
and histamine, synthesised from h is t id in e  (Taylor & Snyder, 1971 ) are 
considered to have d ire c t  action on the e x c i t a b i l i t y * o f  neurones.
3.1 Regional d is t r ib u t io n ,  concentration and central e ffe c ts  of 
monoamines.
The monoamines in human brain (Hornykiewicz, 1964), l ik e  those in 
mammalian brains, (Bodanski, e t  a l . ,  1957) are unevenly d is tr ib u te d  in 
the d i f fe r e n t  brain regions. Dahlstrom and Fuxe (1964) have shown th a t  
most of the c e l l  bodies of the serotonin-producing neurones are concentrated  
in the raphe nuclei of the midbrain, pons and medulla. Serotonin- 
containing f ib re s  have also been detected in unevenly localised areas of 
hypothalamus (Saavedra, et a l ,  1973), the limbic system (Saavedra, e t  a l . ,
1974) and brain stem (Fuxe, 1965). Dopamine and noradrenaline have also 
been reported in the raphe-nuclei of the ra t  (Saavedra, 1977). I t  has 
been indicated as well th a t  while dopamine levels  are low in a l l  raphe 
areas,, the nucleus raphe magnus and nucleus raphe dorsa lis  show r e la t i v e ly  
high noradrenaline levels  equal to about one-th ird  of th a t  of serotonin  
(Saavedra, 1977). The presence of enzymes re la t in g  to the monoamines, 
ty ros ine -  and tryptophan-hydroxylase in the raphe nuclei (Saavedra, 1977), 
ind ica te  th a t  both catecholamines and serotonin can be a c t iv e ly  metabolised
in these areas (Saavedra, e t  a l . ,  1976) and thus be implicated in the
\
regulation  of a number of neurovegetative and behaviour functions (McLean,1952* 
Barchas, e t  a l . ,  1972).
This may, th e re fo re ,  ind icate  th a t  not only the concentrations of 
the amines but also those of th e i r  precursors and metabolites are 
concerned with aminergic function .
3 .2  Transport of monoamines and m etabolites.
The f i r s t  compartment involved in the transport system of monoamines 
in to  the brain is  the 'blood brain b a r r ie r 1. The monoamines themselves 
do not pass the b a r r ie r  to any degree but th e i r  amino acid precursors, 
L-tyros ine  and L-tryptophan, do pass across the b a r r ie r  (Oldendorf, 1971; 
Yudilevich, e t  a l . ,  1972) and subsequently across the neuronal b a r r ie r  to 
reach the ty ros ine -  and tryptophan-hydroxylases responsible f o r  the f i r s t  
step in the synthesis of catecholamines and 5-hydroxyindoles: (Graham-Smith, 
1973). I t  has also been indicated th a t  in terms of tyrosine and tryptophan 
transport,  the neuronal membrane possesses a 'carr ie r-m ed ia ted1 transport  
system which is also active  in counter-transport (Graham-Smith & P a r f i t t ,  
1970).
L-DOPAand L-5HTP are not considered true physiological precursors when 
they enter the brain from the blood, or when they are given by in t r a ­
cerebral in je c t io n ,  since i t  has been indicated (Green & Sawyer, 1964) th a t
when 5-HTP is given to animals the d is t r ib u t io n  of the increased amounts
of serotonin in the bra in -fo llo w s a d i f fe r e n t  pattern from th a t  achieved 
when serotonin is  increased by simply giving MAO in h ib ito rs .  Iversen and 
Callingham (1971) have also shown th a t  the blood brain b a r r ie r  can re tard  
the entry of L-DOPA into the brain by v ir tu e  of the a b i l i t y  of cerebral 
blood vessels to decarboxylate i t  and apparently store the dopamine. 
Furthermore, under certa in  circumstances of amino acid imbalance in the 
blood, the blood brain b a r r ie r  may not be able to maintain the in t r a ­
c e l lu la r  amino acid balance properly (Graham-Smith, 1971).
In view of the monoamine catabolism in the bra in , the metabolites
are transported along the CSF into  the blood and u l t im a te ly  to the urine  
to be excreted, mostly as conjugated compounds. I t  has been reported
(Meek & N eff ,  1973) tha t  about 90% of ra t  brain 5-HIAA is transported  
d ir e c t ly  to the blood while homovanillic acid entering the CNS has been 
estimated (Sourkes, 1973) to account fo r ,  at the most , a th ird  of the  
dopamine turnover of the caudate. Curzon (1976) has indicated tha t  
the concentration of the amine metabolites in CSF vary with d i lu t io n  and 
transport w ith in  the CSF space. For example, v e n tr ic u la r  volume can 
increase considerably on brain shrinkage and lead to d i lu t io n .  Lumbar 
metabolic concentrations are also influenced by the ra te  at which they  
reach the v e n tr ic u la r  sac from the ven tr ic le s  and by t h e i r  transport from 
CSF to the blood. The movement of the metabolites to the lumbar sac, as 
shown on F ig .1.6, may be a lte red  by drugs, i . e .  probenecid (Korf & van Praag, 1971), 
or by neuronal a c t iv i t y  (Post, e t  a l . ,  1973).
D o p a  m i n e  
N o r a d r e n a l i n e
5 - H T
B R A I N F u n c i i o n aN o n - f u n c t i o n a l R e c e  p t  o r s
‘Me t ab o l i t es
V E N T R I C L E S BLOOD
V E N T R I C U L A R  S A C M e t a b o l i t e s
N o r ­
a d r e n a l i n e
5 - H T
. L U M B A R  S A C
Fig. 1.6. Transport of amine metabolites from the brain (Curzon, 1976).
Moreover, un like  the above m etabolites, 3-methoxy-4-hydroxyphenylglycol, 
the major brain noradrenaline m etabolite , does not show a downward 
concentration gradient from the ven tr ic le s  to the lumbar sac (Chase, e t  a l . ,
1973).. In these circumatances, the spinal noradrenaline neurones may make 
a considerable contribution  to i ts  concentration.
3 .3  M etabolic pathways of amino acids
3 .3 .1 .  Tryptophan metabolism
Tryptophan is metabolised in three pathways in addition to protein  
synthesis. These are:
(a) the kynurenine pathway leading to the synthesis of n iacine;
(b) the indole-pathway which p r in c ip a l ly  leads to the synthesis
of serotonin through 5-HTP (Tsuda, e t  a l . ,  1972) and the 
formation of the 3-i.ndole acetic  acid by d i f fe r e n t  
mechanisms, through tryptamine and indolepyruvic acid;
(c) the methoxy-pathway to form melatonin (H ira ta ,  e t  a l . ,  1974)
s p e c if ic a l ly  in the p ineal-g land.
The s tru c tu ra l components of c e l ls ,  antibodies and hormones are p ro te in ,  
and as much as 90% of the c e l lu la r  proteins are contributed by the enzymes 
responsible fo r  fundamental c e l lu la r  functions. The amino acids present in 
protein  molecules, th e i r  position in the molecule and the arrangement of  
the molecule a l l  determine the properties and c h a ra c te r is t ic  of the p ro te in .
(a ) The kynurenine pathway . . „
The metabolism of tryptophan through the kynurenine pathway., in 
mammals, under normal circumstances, occurs mainly by three mechanisms (F ig .1.7).
One involves oxidation of tryptophan to form kynurenine, and subsequent 
conversion to 3-hydroxy a n th ra n i l ie  acid and niacin  and i t s  d e r iv a t iv e s .
The second mechanism involves the catabolism kynurenine to form 2-acetyl-S-CoA,  
and hence tryptophan can be c la s s i f ie d  as a ketogenic amino acid , and 
probably serves as an acetate donor fo r  the formation of the hormone 
melatonin. T h ird ly ,  i t  is metabolised v ia  q u in o lin ic  acid to NAD and NADP.
Gal and Sherman (1978) have demonstrated the presence of an ac tive  cerebral  
metabolism of tryptophan v ia  the kynurenine pathway and th is  leads to the 
presumption of n iac in  synthesis in the bra in . Kynurenine is synthesised 
by indoleamine-2.3 -dioxygenase in the brain (Hayaishi, 1975), an enzyme 
which resembles the tryptophan-pyrrolase. (or try p to p h an -2 .3 -dioxyenase)
!iO
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which normally occurs in mammalian l iv e r  (Knox & Mehler, 1950). This 
pathway has been demonstrated in vivo (Gal, e t  a 1.., 1966) and a lso , in v i t r o  
(Gal, 1974). Like tryptophan-pyrrolase, th is  enzyme is inducible  by 
tryptophan loading (Gal, 1974). Induction leads to an increase o f a 
cerebral pool of kynurenine and i t s  m etabolites, as well as increasing i t s  
own synthesis from tryptophan (Gal, e t  a l .., 1977). As the indoleam ine-2.3-  
deoxygenase has been shown to have s im ila r  properties to hepatic tryptophan- 
pyrro lase, i t  may be assumed th a t  i t  is  inducible by oestrogen (Rose, 1956) 
and insu lin  (Schor & Frieden, 1959). However, th is  cerebral enzyme, unlike  
the hepatic pyrro lase, is not inducible  by cort icos te ro id  (Rapoport &
Beise l, 1968) or by a-MTRP (a-m.ethyl tryptophan) (Green & Curzon, 1968;
Sourkes, e t  a l . ,  1970). Not only is  tryptophan pyrrolase induced by a 
number o f hormones, and by i t s  substrate, but i t  is also in h ib ite d  by n iacin  
(Cho-Chung & P i t o t ,  1968) and the reduced forms of niacin co -fac to rs , NADH 
and NADPH, are esp ec ia lly  e f fe c t iv e  as in h ib ito rs  (Cho-C.hung & P i t o t ,  1967).
I t  has also been claimed that a number of metabolites of the kynurenine 
pathway, such as 3-hydroxyanthranilic  acid (Wagner, 1964) and metabolites  
of the indole pathways; namely 5-hydroxytryptophan and serotonin, in h ib i t  
the tryptophan-pyrrolase a c t iv i t y  (Frieden, et a l . ,  1961). A number of 
methylated der iva t ives  of tryptophan, fo r  example, tryptophol and N -ace ty l-  
tryptamine, also in h ib i t  tryptophan-pyrrolase (Madras & Sourkes, 1968).
In add ition , catecholamines act also as in h ib ito rs  (Frieden, e t  a l . ,  1961). 
Further investigations of a s im ila r  nature w i l l  be required fo r  indoleam ine-2 .3-  
dioxygenase in terms of i t s  regulatory fac to rs ;
Both kynurenine and 3-hydroxykynurenine are substrates fo r  the enzyme 
kyneureninase, a pyridoxal phosphate (PLP) -  dependent enzyme which catalyses  
the formation o f a n th ra n i l ic  acid and o f  3 -hydroxyanthranilic  acid (Gal,  
e t  a l . ,  1966). A defic iency of vitamin Bg resu lts  in some degree of  
f a i lu r e  to catabo lise  these d e r iva t iv es . Hence the formation of n iac in
from tryptophan w i l l  be reduced and tryptophan metabolism is  d iverted to 
the formation of xanthurenic acid and 8-hydroxyquinaldic acid. These 
abnormal metabolites have been id e n t i f ie d  in the urine of man, the monkey 
and the ra t  when the d ie ta ry  intakes of vitamin Bg were inadequate. Thus, 
the excretion of these compounds, fo llow ing a tryptophan-load, can be used 
in the assessment of vitamin Bg status. In add ition , kynurenic acid and 
quinald ic  acid are by-products of kynurenine through transamination. 
Henderson, e t  a l . , (1956) claimed th a t  3 - hydroxyanthran ilic  acid can 
replace nicotinamide or tryptophan in supporting the growth of r a ts , ,  
but the d ie ta ry  requirement fo r  3- hydroxyanthran ilic  acid is much higher 
than th a t  fo r  nicotinamide. Hankes and Henderson (1957) found th a t
i h
labe lled  C -3 -hydroxyanth ran ilic  was converted to highly lab e lled  N*" 
methylnicotinamide and q u ino lin ic  acid in the r a t .  Moreover, Nishizuka 
and Hayaishi (1963) showed the conversion of the intermediate q u in o lin ic  
acid to nicotinamide mononucleotide, in the presence of 5-phosphoribosyl- 
1-pyrophosphate and thus to NAD. They found th a t  nicotinamide mononucleotide 
is also an intermediate in the conversion of n ic o t in ic  acid to NAD. 
a-Amino-3-carboxymuconic semialdehyde is formed in the course o f the 
oxidation of 3 -hydroxyanthranilic  acid (Mason, 1957). The non-o.xidative 
decarboxylation of th is  compound by the enzyme p ic o l in ic  acid decarboxylase, 
which occurs spontaneously to form p ic o l in ic  acid, involves the loss of the 
o r ig in a l carboxyl-group of 3 -hydroxyanthranilic  acid (Mehler & May, 1956). 
Furthermore, Mehler, et/ a l (1958)  suggested th a t  the increase in p ic o l in ic  
acid decarboxylase a c t iv i t y  in the d iabetic  r a t  is associated with decreased 
excretion of N*- methylnicotinamide, and cortisone or re la ted  adrenal 
hormones, are required fo r  the enzyme a c t iv i t y .  Gholson and his colleagues 
(1962) reported tha t th is  enzyme catalyses the oxidation of a-amino-3- 
carboxymuconic semialdehyde to form aminomuconic acid. The aminomuconic 
acid undergoes an ox idative  deamination to a-oxoadipic acid, which can be
metabolised fu r th e r  to yield 2-acetyl-SCoA. In ca lcu la t in g  the cerebral 
ra te  o f formation of kynurenine from tryptophan, the continuous f lu x  of 
kynurenine from plasma into  the brain has been taken into  account and th is  
represents about 60% of the cerebral pool of kynurenine and the balance of 
the pool of kynurenine or 3-hydroxykynurenine in the brain re f le c ts  th e i r  
synthesis in s i tu  (Gal & Sherman, 1978). I t  has also been indicated tha t
the r a t io  of kynurenine synthesised by the brain to exogeneous kyneurenine
is nearly  h a l f .
(b) Indole-p.athways .
Serotonin is the major product o f the indole-pathway, shown in F i g . 1.8 .
The f i r s t  step is the hydroxylation of tryptophan catalysed by tryptophan
hydroxylase, the r a te - l im i t in g  enzyme, to form 5-HTP which is subsequently 
decarboxylated to form serotonin. Under normal circumstances serotonin is  
mainly catabolised by the action of MAO to y ie ld  5-hydroxyindole acetaldehyde, 
and subsequent oxidation by aldehyde-dehydrogenase to 5-HIAA.
In mammals a small proportion of brain tryptophan is catabolised by 
d i f fe r e n t  routes to y ie ld  3-indo ie  'acetic acid (IAA). One route involves  
the action of MAO and aldehyde dehydrogenase on tryptamine, the a-decarboxy- 
la t io n  product of tryptophan (Weissbach, e t  a l . ,  1959), while the other  
intermediate, is converted by amino transferase to irtdolepyruvic acid , with  
subsequent ox idative  decarboxylation.
(c) Methoxy-pathways
A number of other acetylated and methylated d er iva t ives  of serotonin  
are formed in p a ra l le l  with the main indole-pathway, as shown in F i g . 1.8 , 
and these have considerable pharmacological a c t i v i t y  in the centra l nervous 
system (Koslow, 1974). Melatonin (N -a c e ty l-5 -  methoxyserotonin), a hormone 
synthesised mainly in the pineal gland from tryptophan, and also to some 
extent in the peripheral nerve of man, monkey and bovine species, (Lerner,  
e t a l . ,  1959), is derived from serotonin by N -acety lation  in which acetyl-CoA

serves as acetate donor, followed by 0-methylation (Koslow, 1974) of the 
5-hydroxy group in which S-adenosyl methionine serves as methyl donor (~CH*) 
to ac t iva te  indoleamines and in a c t iv a te  catecholamines and histamine (Axelrod 
& Weissbach, 1961). There -is also an ind ication  (Guchhait, 1976) th a t  
the pineal gland has the a b i l i t y  to synthesise other methylated indoleamines, 
such as N, N-dimethyltryptamine, 5-hydroxy-N, N-dimethyltryptamine and 5 -  
methoxy-N,N-dimethyltryptamine when the reaction medium is f o r t i f i e d  with
S-adenosylmethionine. Kveder and Mclsaac (1961) found some id e n t i f ia b le  
metabolites o f serotonin in the urine a f te r  adm inistration of melatonin.
One of these was N-acetyl-6-hydroxy-5-methoxytryptamine which was present 
as sulphate and glucuronic acid conjugates. Other metabolites were non- . 
indole reacting compounds. They also found th a t  5-methoxytryptamine 
indo leacetic  acid was excreted a f te r  adm inistration o f methoxytryptamine.
Methoxytryptamine in the brain is ,  l ik e  serotonin, metabolised to the 
corresponding acid by the action of MAO. When MAO is  in h ib ite d  a number of 
metabolites are excreted. One of these, serotonin glucuronide is found in 
the r a t  but not in man, although some serotonin-O-sulphate is  formed (H arp er ,1971).
3 .3 .2 .  Tyrosine and phenylalanine metabolism
Under normal circumstances in mammals phenylalanine can be converted 
in to  tyrosine (Udenfriend & Cooper, 1952). This reaction is catalysed by 
phenylalanine hydroxylase in the l iv e r  and requires NADPH fo r  reduction of 
dihydrobiopterin in to  te trahydrob iopterin  (BHJ as co -fac to r  (Kaufman, 1963;
Harper, 1971) (Fig. 1.9 )
I t  can be in fe rred  from n u tr i t io n a l  experiments (M e is ter ,  1965) th a t  
a s u f f ic ie n t ly  high level of d ie ta ry  phenylalanine can replace the req u ire ­
ment fo r  d ie ta ry  tyrosine.- On the other hand, the reaction is  i r r e v e r s ib le
(Grau & S te e l ,  1954), th e re fo re ,  ty ro s in e  cannot replace the d ie ta ry  
requirement f o r  phenyla lan ine .
L “  P h e n y l a l a n i n e
Fig . 1.9. The phenylalanine hydroxylase reaction (Harper, 1971)
A c t iv i ty  I :  the reduction o f  02 to H20 and conversion o f
L-phenylalanine to L -ty ro s in e .
A c t iv i ty  I I :  ca ta lys is  redaction of d ihydrobiopterin  by NADPH.
The metabolism of tyros'!ne can be divided in to  fo u r  main pathways. 
They are; (a )  l i k e  tryptophan, ty ro s in e  can be converted d i r e c t ly  to 
form acetyl-CoA and fum aric acid w ithout f i r s t  forming pyruvic acid  
(W inick, e t  a l . ,  1948); (b) ty ro s in e  is  a d i r e c t  precursor o f dopamine
noradrenaline and adren a line  (Udenfriend & Wyngaafden, 1956) as w ell as 
other th y ro id  hormones (M e is te r ,  1965); : (c) thyrox ine  and th io - io d o -  
thyron ine; (d) synthesis o f  melanin (Lerner, 1953).
(a) Formation of acetyl-CoA and fumaric a c id .
There are three main enzymatically  catalysed reactions involved in 
the conversion of tyros ine  to acetyl-coA and fumaric acid ( F i g . 1 .10);
1) The transamination of tyrosine to p-hydroxyphenylpyruvic acid (La Du & 
Greenberg, 1951) is  catalysed by ty ro s in e -a -k e to g lu ta ra te  transaminase.
This enzyme appears to be inducible  and may be s im ila r  to th a t  which 
catalyses the transamination of tryptophan (Freedland, 1963).
2) p-Hydroxyphenylpyruvate is oxidised to homogentisic acid by p-hydroxy- 
phenylpyruvate-hydroxylase (Neuberger, 1949), which appears to be a copper- 
dependent oxygenase. Ascorbic acid has also been suggested as a co -fac to r  
fo r  th is  enzyme since in avitaminosis C there is  de f e c t iv e  formation of 
homogentisic acid and also increased urinary  excretion of p-hydroxyphenyl­
pyruvic acid (Udenfriend, e t  a l . ,  1954).
3) The conversion of homogentisic acid to fumaric acid and aceto -acetic  
acid is in i t ia te d  by oxidation to  m aleylacetoacetate, a reaction catalysed  
by homogentisic acid oxidase (Knox & Edwards,- 1955) -  an enzyme wh^ch 
requires ferrous ions (Tokuyama, 1959). The conversion of maleylacetoacetate  
to fu m ary lace to ace ta te  is  catalysed by maleylacetoacetate isomerase, a 
sulphydryl enzyme present in mammalian l iv e r  which has an absolute req u ire ­
ment fo r  the reductant t r ip e p t id e  glutath ione and ascorbic acid f o r  i t s  
a c t iv i t y  (Edwards & Knox, 1956). Subsequently, the hydrolysis o f fum aryl- 
acetoacetate, catalysed by fumaryl-acetoacetate hydroxylase forms fumaric  
acid and aceto -acetic  acid which can then be converted to acetyl-CoA and 
acetic  acid by the 3-ke to th io lase  reaction (Harper, 1971).
(b) Catecholamines-pathways
The synthesis of dopamine, noradrenaline and adrenaline through DOPA 
(F ig .1.11) is catalysed by tyrosine-hydroxylase, which appears to be very  
s im ila r  to e i th e r  phenylalanine- or tryptophan-hydroxylase (Nagatsu, e t  a l . , 1
-dtf-
F ig. 1.10. Formation of acetyl-CoA and fumaric acid (Bender, 1975).
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Subsequently, the enzyme DOPA-decarboxy.lase catalyses the formation of 
dopamine ( 3 , 4-dihydroxyphenylethyl amine) (Leeper & Udenfriend, 1956), 
which is then converted in to  noradrenaline by dopamine-e-hydroxylase,
(Hagon, 1956). In the adrenal medulla, the noradrenaline is  fu r th e r  
metabolised to adrenaline by N-methylation, using S-adenosylmethionine 
as the methyl donor to the enzyme phenylethanolamine-N-methyl transferase  
(Axelrod, 1962).
Homovanillic acid is the major excretory product- of the catabolism  
of dopamine (Shaw, e t  a l . , 1957). The degradation is  catabolized by two 
enzymes, MAO and COMT. (F ig . l ;1 i ) .  The immediate product of MAO a c t iv i t y  
is the aldehyde corresponding to the amine; th is  is  rap id ly  oxidised to • 
the corresponding acid by aldehyde dehydrogenase to form DOPAC (3 ,4 -  
dihydrophenylacetic acid) (Youdim, et. a l . , 1969). COMT requires S-adenosyl- 
methionine fo r  methylation of the 3-hydroxyl groups of dopamine (Axelrod & Tomchi
1958) to form 3-methoxytyramine (W illiam s, e t  a l . ,  1960).
*>
The major pathway of metabolism of c irc u la t in g  adrenaline and nor­
adrenaline in man and other mammals involves in ac t iv a tio n  by methylation  
of the 3-hydroxyl groups of these compounds to y ie ld  metanephrene and 
normetanephrene respective ly  (M eis ter, 1965). One of the p r in c ip a l  
metabolites of adrenaline and of noradrenaline is 3 ,4 — hydroxymandelic 
acid which is excreted in the form of 4-hydroxy- 3-methoxymandelic acid ,  
also ca lled  vaniImandelic acid (VMA). Another m etabolite occurring in  
the urine in s ig n if ic a n t  quantit ies  is  3-methoxy-4-hydroxyphenylglycol 
and a minor excretory product is the catechol (dihydroxy-compound) which 
corresponds to the methylated compounds, 3,4-d.ihydroxyphenylglycol 
and v a n i l l i c  acid (Harper, 1971).
(c )  Formation of thyroxine and t r i - io d o th y ro n in e . ( F i g . 1.12.)
Tyrosine can be iodinated in the thyroid  gland, f i r s t  mono- and 
then d i- io d o ty ro s in e , under the action of iodina.se.'.' Both iod ine-  
containing compounds are then converted to e i th e r  tr i - io d o th y ro n in e  (T^)
(Roche & M ichel, 1955), or thyroxine ( te tra - io d o th yro n in e , T^) (P i t t -R iv e r s ,  
e t  a l . ,  1955) re sp e c t ive ly ,  by a so-called  ‘coupling enzyme.' M eister (1965),  
has indicated th a t  thyroxine and the other iodinated compounds are incor­
porated into  thyrog lubulin , and also occur in the f re e  s ta te .
In hypothyroidism there is  defective  production of thyroxine and, 
consequently, abnormally low c irc u la t in g  levels  of thyroxine and t r i ­
iodothyronine. This condition is characterised by a general mental apathy 
and, in severe adult hypothyroidism, by myxoedema. Cretinism is the 
re s u lt  of in f a n t i le  hypothyroidism and is accompanied by mental re ta rd ­
a tio n . In con trast, h yp erac t iv ity  of the thyroid may re s u l t  in abnormally 
high c irc u la t in g  levels  of thyroxine and iodinated compound and is  
characterised by nervous ag ita t io n  and a raised basal metabolic ra te .
(d) Melanin synthesis
Melanin pigments are synthesised from tyrosine in the skin , ( F ig .1.13).
The f i r s t  step is the formation of a dihydroxyindole d e r iv a t iv e ,  DOPA, 
under the action of tyrosinase, a copper-containing oxygenase (Kubowitz,
1938). DOPA is then oxidised to dopaquinone . (3 ,4 -d ioxyphenylalanine)
(Mason, 1 95 5 ) .and subsequently to 2-carboxy-2,3-d;ihydro-5,6-d .ihydroxyindole, 
which is then decarboxylated to y ie ld  5 ,6 -  d ihydroxyindole . This compound 
is  then reduced to indole-5,6-quinone which undergoes polymerisation to  
form melanin. Bender (1975) has indicated th a t  albinism in mammals is  due 
to a defic iency of tyrosinase a c t iv i t y  leading to a f a i l u r e  of melanin
.1.12. Formation o f thyroxine and tr i- io d o th y ro n in e .
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synthesis. I t  has been reported th a t  COMT from r a t  l iv e r  catalyses  
the methylation o f  5 , 6-dihydroxyindole and of 5,6-dihydrodihydroxyindole.
On the other hand, hydroxyindole-O-methyltransferase, found in the 
pineal gland, catalyses the methylation of 5,6-d ihydroxyindole, but 
does not methyl ate 5,6-dihydrodihydroxyindole. I t  has also been 
suggested th a t  0-methylation is o f s ign ificance in regulating melanin 
formation (Axelrod & Lerner, 1963)
There is  a considerable amount o f melanin in the substantia n igra  
of the brain and here i t  is  formed by polymerisation of dopamine (Sandler  
& Ruthven, 1969). The mechanism of the formation of th is  neuromelanin 
s t i l l  requires in ves tig a t io n .
3 .3 .3 .  Other s y n a p t ic a l ly -a c t iv e  amino acids *
GABA (x-aminobutyric acid) was the f i r s t  amino acid fo r  which strong 
evidence of a neurotransmitter ro le  was obtained (Iversen , 1972). Other 
amino acids, such as glutamic acid, _asparic acid and g lycine, have been 
suggested as neurotransmitters in the mammalian CNS (Henn & Hauberger, 1971). 
I t  has also been suggested th a t  brain histamine which have many character­
is t ic s  resembling the other biogenic amines (Snyder & Taylor, 1972), also 
functions as a neurotransm itter. This amino acid is  synthesised from 
h is t id in e  by a s p e c if ic  h is t id in e  decarboxylating enzyme which can be 
in h ib ited  by a - 'hydrazine-h is tid ine (Levine, et a l . ,  1965), or by the 
aromatic amino acid decarboxylase (Lovenberg, e t  a l .:, 1962). There s t i l l  
remain many incomplete connections in th is  subject fo r  which fu r th e r  
d e ta i le d  studies are necessary.
There appears to be a d iffe rence  in the transport capacities  o f  amino 
acids which function as p u ta t iv e  transm itters  and the biogenic amine 
precursors between blood and bra in . The biogenic amine precursors,
phenylalanine, tyros ine  and tryptophan have a high transport capacity ,  
whereas the f lu x  rates of GABA, g lyc ine, glutamic acid and aspartic  acid 
are extremely low (Oldendorf, 1971; Yudilevich, et a l . ,  1972):.in sp ite  of the 
evidence th a t  these amino acids play a d ire c t  ro le  in neurotransmission. 
Glutamine can be considered a precursor of glutamic acid and then of  
GABA, and the ra te  of transport of th is  precursor into  the brain has 
been found to be very low (Olderdorf & Szabo, 1976). Although these 
amino acids enter the brain from the blood only slowly, when in jected  
in t r a c is te r n a l ly ,  thus by-p.assing the blood brain b a r r ie r ,  glutamic acid 
(B e r l ,  1973) and glycine (Aprison, e t  a l . , 1975), are ra p id ly  metabolised 
w ith in  the bra in . These amino acids are also synthesised from non-amino 
acids. Thus, fo llow ing a systemic in je c t io n  of C-glucose, the label is  
ra p id ly  incorporated in to  brain GABA, glutamic acid, aspartic  acid and 
glycine (Cremer, 1964; Shank & Aprison, 1970).
Furthermore, the enzyme glutaminase I ,  is  a mitochondrial enzyme 
(Bradford & Ward, 1976) located in nerve endings, together with the other  
enzyme system ( i . e .  c i t r i c  acid c yc lic  cycle, transaminases) which' convert 
glutamine into  glutamic acid and aspartic  acid (Bradford, e t  a l . ,. 1978).
These studies may, thus, ind icate  an important ro le  of glutamine, probably 
as a p r in c ip a l precursor of aspartic  acid, glutamic acid and GABA.
Since glutamic acid and GABA e x e r t ,  respec tive ly , e x c ita to ry  and 
depressant actions in the bra in , th is  re la tionsh ip  may be of considerable  
sign ificance  in determining the balance between exc ita t io n  and in h ib it io n  
of the brain (Davidson, 1976).
3 .4  Functional in te rac tions  between serotonin and catecholamines
In te rac tio n s  between the catecholaminergic (dopaminergic and nor- . 
adrenergic) and serotonergic systems have been demonstrated a t some
fu n c t io n a l,  neurochemical or neuropharmacological leve ls .  C o s ta l l ,  
e t a l . ,  (1976) have reported th a t  b i la te r a l  in je c t io n  of dopamine or 
noradrenaline in the nucleus accumbens of ra ts  pretreated with an MAO- 
in h ib i to r  causes a s t r ik in g  dose-dependent motor h yp erac t iv ity  which 
can be reduced by in je c t io n  of serotonin into the nucleus accumbens.
This ind icates th a t  a dopaminergic a c t iv i t y  is  modulated by serotonergic  
in h ib i t io n .  On the other hand, Commissiong and Sedgwick (1979) have 
demonstrated th a t  intravenous L-DOPA causes a dose-dependent depletion of 
serotonin in the lumbar region of r a t  spinal cord. Pretreatment with  
the peripheral dicarboxylase in h ib ito r ,  s ig n i f ic a n t ly  increased the  
serotonin d e p le t in g -e ffe c t  of acutely administered L-DOPA, whereas 
chron ica lly  administered L-DOPA had no e f fe c t  on spinal serotonin leve ls  
24 hours a f te r  the la s t  dose. This may, there fo re , ind icate  th a t  the  
L-DOPA-mediated depletion of serotonin from serotonergic terminals  
occurs in the brain and spinal cord. Some other studies have also 
reported tha t  adm inistration of L-DOPA causes not only an increase in 
brain dopamine but also a decrease in brain serotonin (Ng, e t  a l .., 1972). 
Conversely, treatment with 5-HTP increases brain serotonin but decreases 
brain dopamine in ra ts  (Johnson, e t  a l . , 1968; Bose, et al.. ,  1974).
This in te ra c tio n  between dopamine and serotonin appears to be due to 
competition fo r  the enzyme DOPA/HTP decarboxylase, which is common to 
the biosynthesis of both amines.. Pradham and Bose (1978) have indicated  
th a t  a cen tra l serotonin mechanism antagonises amphetamine-induced 
catecholaminergic h y p e ra c t iv ity .  Wood and Mayer .(1979) have also 
suggested th a t  the mechanism of the blocking action of noradrenaline is  
in h ib it io n  of release of the exc ita to ry  neurotransmitters from pre-  
synaptic nerve term inals . This is probably one of the mechanism th a t  
is  involved in supression of serotonergic innervation of GIT (gastro - . 
in te s t in a l  t r a c t )  motor function during ac t iva t ion  o f the sympathetic 
innervation o f the in te s t in e .  I t  has been reported th a t  the pineal
gland, innervated by noradrenergic nerve f ib re s  from the superior  
cerv ica l ganglia , shows a c ircadian rhythm in i t s  serotonin level  
(Deguchi & Axelrod, 1972; Klein & Yuwiler, 1973). These workers have 
suggested th a t  in pineal organ cu ltu res , and possibly, in ViVoy nor- 
adrenaline stim ulates seroton in -N -acety ltransferase , the enzyme responsibl 
fo r  the formation of melatonin. This enzyme has a l ig h t -d a rk  cycle rhythm 
Thus, under normal conditions serotonergic neurones might exert an 
in h ib ito ry  action on some noradrenergic system at the onset of sleep.
A lesion in a cen tra l noradrenaline s tructure  causes an increased tu rn ­
over of serotonin and may lead to hypersomnia. A sleep-waking cycle is  
regulated by two in te ra c t in g  ascending systems of adrenergic and sero­
tonergic neurones (Jouvet, 1974; Kostowski, et. a l . . , 1974). Additional 
evidence (Ruch-Monaliou, e t  a l . ,  1976) th a t  the rapid-eye-movements 
(REM) phase of sleep in the cat involves an in te ra c tio n  between nor­
adrenaline and serotonin function .
4. CONCLUSIONS AND PLAN OF PRESENT STUDIES
The metabolic pathways discussed above form a basis fo r  the action  
of drugs used in the treatment of neurological and psych ia tr ic  i l ln e s s .
In general, drugs th a t  increase the level of brain noradrenaline in the  
synapse have an antidepressant e f fe c t ,  whereas those th a t  lower i t s  
level in the brain tend to exacerbate depression. Drugs th a t  block 
centra l dopamine receptors are useful in t re a t in g  psychoses, whereas 
those th a t  stim ulate  receptors seem to b e n e fit  the p a t ien t  with  
Parkinson's disease. Other investigations of sero ton in -re la ted  functions  
in depressed p atien ts  have yielded equivocal re s u lts ,  although p o te n t i ­
ation of the therapeutic  e f fe c ts  of anti-depressant drugs are in agreement 
with animal pharmacological studies ind icating  th a t  anti-depressant drugs 
act in part  v ia  serotonergic mechanism.
Recent observations ind icate  th a t  n u tr i t io n a l  fac tors  also exert  
major influences on brain leve ls  of neurotransmitters, catecholamines 
and serotonin. As a re s u l t ,  attempts are being made to t r e a t  some 
i l lnesses associated with abnormal levels  of neurotransmitters by 
adm inistration of p a r t ic u la r  n u t r i t io n a l  constituents. Pharmacalogical 
doses of p a r t ic u la r  nu tr ien ts  can, probably, be used to a l t e r  the brain  
neurotransmitter level fo r  therapeutic  purposes. The p a r t ic u la r  d ie ta ry  
constituents th a t  a f fe c t  these transm itters  tend to be to le ra ted  well and 
thus th e i r  e f fe c ts  on the brain may provide add itional approaches in the 
treatment of brain disease. This p o s s ib i l i t y  may introduce a new concept 
of medical treatment th a t  is d i f fe r e n t  from th a t  underlying the use of 
conventional synthetic drugs.
In the l ig h t  of these conclusions, i t  was decided to study the various  
aspects of the metabolism of serotonin in three d i f fe re n t  parts o f the  
brain of adult ra ts .  The study was extended to include on inves tiga t ion  
of the ways in which n u tr i t io n a l  manipulations a f fe c t  th e c o n tr o l  of the 
serotonin metabolism in the bra in , with p a r t ic u la r  reference to the e f fe c t  
on la rge-neutra l amino acids and a r a te - l im i t in g  enzyme. Since brain  
serotonin is known to be associated with brain functions, in terms of  
neurophysiological processes, the e f fe c ts  on the behaviour and physical _ 
a c t iv i t y  of the ra ts  have also been observed.
I t  is hoped th a t  th is  work w i l l  furn ish  information th a t  could be 
useful in the treatment of certa in  psych ia tr ic  disorders.
CHAPTER 2 
MATERIALS AND METHODS
2.1 Experiments
2 .1 .1 .  Animals
Wistar albino ra ts ,  o r ig in a l ly  from a Medical Research Council SPF 
s tra in  were used throughout. The ra ts  have been inbred in the Un ivers ity  
Animal Unit under normal heating conditions (24° -  2°C) with 50 -  .60% 
humidity and a lte rn a t in g  12 hours cycles of l ig h t in g .  Female ra ts  aged 
2 to 3 months were used fo r  a l l  experiments. The rats  were caged 
in d iv id u a lly  throughout the experiments in hanging polyethelene cages 
with z inc -p la ted  grids (Bowman L im ited ).  They were given a normal d ie t  
and drinking water ad l ib itu m .
2 .1 .2 .  Composition of d ie t
Spratt Laboratory D iet No.l (expanding breeding d ie t )  in a powdered 
form was supplied by Spratts Laboratory Service. The d ie t  was given 
ad l ib itu m  to both the control and experimental animals. The composition 
of stock d ie t  is shown on Table 2 .1 .
2 .1 .3 .  Administration of tryptophan, n ic o t in ic  acid and in s u l in .
Groups of ra ts  were assigned to d i f fe re n t  regimens in the d i f fe r e n t  
experiments. Tryptophan (50~mg/kg body weight) and n ic o t in ic  acid 
(60 mg/kg body weight) were dissolved in d is t i l l e d  water and given as a 
single do-se (2 m is .)  o r a l ly ,  by a stomach-tube. Subconvulsive doses of  
insu lin  (2U/kg) were dissolved in sa line  (4U/ml) and in jected  peritone-  
a l ly .  These amounts were given d a i ly  at the same time (9 .00  am -  .10.00 am.) 
During th is  time the animals were weighed.
Table 2 .1 .  Composition of Laboratory Animal Diet  per kilogram of d ie t .
Powdered d ie t  fo r  Rodent 
Chemical composition Unit  (Expanded)____
Moisture 9 80
Ether e x t ra c t /F a t  g 45
Crude protein  g 215
Crude f ib r e  g 27
Total d ig e s t ib le  nu tr ien ts  g 780
Vitamin and mineral composition
Lysine g 11
Methionine 9 3.9
Calcium g 9
Phosphorus g 8
Vitamin A IU 1100
Vitamin Dg IU 1200
Alphatocopherol IU 24
Vitamin Kg mg 10
R ib o f la v in ' mg 7
Pyridoxine mg (added) 1
Panthotenic acid mg 17
N ico tin ic  acid mg 80
F o lic  acid mg 0 .2
Choline ch loride mg (added) 450
Cyanocobalamine meg 15
Manganese mg 65
Iron mg 100
Iodine mg 0 .5
Copper mg 20
Zinc mg 40
Cobalt mg 1
2.2 A na ly tica l Procedure
2 .2 .1 .  Chemicals
The chemicals used in the various an a ly t ica l procedures were as follows
(a) Standards:
L-tryptophan, 5-hydroxytryptamine crea tin in e  sulphate (serotonin, 5-HT) 
5-hydroxyindole acetic  acid (5-HIAA), pa lm it ic  acid, bovine serum albumin 
were a l l  obtained from the Sigma Chemical Company; hydrolysate amino acid 
standard, consisting of aspartic  acid , threonine, serine, aspargine, 
glutamic acid, p ro l in e ,  g lyc ine , a lanine, cystine , v a l in e ,  methionine, 
isoleucine,' leucine, ty ros ine , phenylalanine, h is t id in e ,  o rn ith in e ,  lys in e ,  
ammonia and argin ine was purchased from LKB Instruments Limited. Each 
amino acid was present at a concentration of 2.5 ymole/ml, except fo r  
cystine which was present at a concentration of 1.25 ymole/ml.
(b) Buffers:
( i )  0 .5 M phosphate b u ffe r ,  pH 7 .0 ,  was prepared from 0.5M
potassium dehydrophosphate (KH2 P0^; -MW = 136.09) and 0 .5  M disodium 
hydrophosphate (Na2 H P O ^ H j;  MW = 358 .14 ). The pH of 7 .0  was adjusted  
by mixing both solutions at approximately 1:2 by volume resp ec tive ly .
( i . i )  Sodium acetate b u ffe r  was prepared as fo l lo w s :-  
Sodium acetate (5 X 554 gr).was dissolved completely in about 4 l i t r e s  
of d i s t i l l e d  or deionised water. I t  was warmed, i f  necessary, before  
adding 500 mis g la c ia l  acetic  acid. The pH of th is  solution was adjusted  
to 5.51 ± 0.63 with NaOH and th is  volume made up to 5 l i t r e s .  The 
solution was f i l t e r e d  before use.
( i i i )  Sodium b u ffe r  system fo r  single column protein hydrolysate  
consisted of various b u ffe rs , as fo l lo w s :-
Buffer A Buffer B Buffer C NaOh
pH 3.25 4.25 6.45 -
Normality (Na) 0 .2 0 .2 1.2 0 .4
Sodium c i t r a t e  2H20 gr/1 19.6 19.6 19.6 -
Thiodiglycol/m l 5 .0 5.0 - -
Phenol gr/1 1.0 1.0 1.0 -
Sodium hydroxide gr/1 - - 40.0 16.0
10 .ON HC1/ml ca .12 .3 ca .8 .4 ca .83 .2 . —
Water to 1 1i t r e
( iv )  T r is  acetate b u ffer  pH 7.6  
500 mis of 0.05M tr izm a-aceta te  (Sigma) was adjusted to pH 7.6. with  
± 250 mis of 0.05M trizma-base (Sigma).
(c) Solvents: A l l  the solvents were an a ly t ica l grade and were obtained
from BDH Chemicals Limited.
(d) Solutions:
( i )  Standard stock solutions:
Tryptophan standard (100 yg/mT) was prepared in O.IN'NHs solution and 
was stored in a cold room (4°C ). The 5-HT standard (100 jug/ml) was made 
up from 22 mg 5-hydroxytryptamine-creatinine sulphate or 10 mg pure 
hydroxytryptamine in 100 mis deionised water and was stored a t -25°C.
The 5-HIAA standard solution containing 15 yg/ml in deionised water was 
stored at -25°C. The NEFA standard (0 .5  mM f a t t y  ac ids/1) was prepared 
by weighing out 12.82 mg of pa lm it ic  acid or 14.22 mg of s te a r ic  acid and 
r ins ing  in to  a 100 ml volumetric f las k  with chloroform. The f la s k
was stoppered and stored in a dark place at 15° to 25°C. I t  was s tab le
fo r  six months. The standard of bovine serum albumin (500yg/ml) was 
c a re fu l ly  dissolved in d is t i l l e d  water and stored in the cold room.
The protein  hydrolysate standard was d ilu ted  1 to 25 in 3% (w/v)  
su lphosa licy lic  acid and was stored at -25°C.
( i i )  Reagents
The ninhydrin reagent was prepared in a brown b o t t le ,  as fo l lo w s :-  
2,800 mis ethylene glycol (ethanedio l)  or 3,000 ml 3-methoxyethanol was 
poured in to  the b o t t le .  Nitrogen was allowed to f lo w th ro u g h  the  
l iq u id  fo r  about 15 minutes. The nitrogen was then stopped and 
exactly  40g ninhydrin was poured into the b o t t le .  The beakers and 
funnels were rinsed with a few ml of solvent. The flow of nitrogen  
was then.opened again and the b o t t le  was occassionally shaken u n t i l  
the ninhydrin had dissolved and 1,200 mis acetate b u ffe r  was added.
I f  methoxyethanol was used, 1 l i t r e  only of acetate bu ffe r  was added. , 
The nitrogen was passed through the mixture fo r  another -15 minutes. 
Subsequently, l ,600g  stannous chloride  (SnCl2 2H20) was added and 
c a re fu l ly  mixed. The ninhydrin solution was ready fo r  use 2 -  .3 hours 
a f te r  preparation.
Test-combination k i t  fo r  n o n -es te r if ied  f a t t y  acids (NEFA) 
(Boeringer, Mannheim GmbH, Diagnostica) contains b u ffe r /c u p r ic  n i t r a t e  
reagent.which consists o f 0.45M/1 tr ie th a n o l amine b u ffe r  pH 7 .8  and 
0.27 M/1 cupric n i t r a t e ,  and 9mM/l d ie thy ld ith iocarbonate .
Fo lin  and C ioca lteu 's  reagent was obtained from Sigma.
n-Butanol was a c id i f ie d  by adding 0.85ml concentrated HC1 to 
1 l i t r e  o f n-butanol (Chang, 1964).
2 . 2 . 2 .  Analy t ica l  methods
( a) Sample c o l le c t io n :
At the end of the experiments the animals were anaesthetised with  
anaesthetic ether a t  approximately the same time of the day (9 am -  11 am) 
to  avoid the in te r fe r in g  e f fe c ts  of diurnal va r ia t io n s . Blood was w ith ­
drawn by cardiac puncture (about 6 -  .8 mis per -  200 gr. r a t ) ,  using an 
heparinised syringe and then transferred  to a centrifuge tube. The plasma 
was separated by cen tr ifug a tion  and 1.5 ml fresh plasma u l t r a - f i l t e r e d  
in a CF50 D ia f lo  membrane cone (Amicon Limited) was subsequently c e n t r i ­
fuged at 2,500 rpm fo r  30 minutes at 10°C and used fo r  the determination  
of f re e  (unbound) tryptophan. The u l t r a f i l t r a t e  and the res t  of the plasma 
were stored at -50°C u n t i l  assayed.
(b) Removal and dissection of the brain
The animals were decapitated with a g u i l lo t in e  immediately a f te r  the
bleeding procedure and the head was immersed in s ta n t ly  in l iq u id  nitrogen  
(-196°C) fo r  5 seconds. The whole brain was rap id ly  removed. The 
cerebellum was removed, by separation of the cereb e lla r  peduncles and the 
forebra in  was separated from the remainder, ca lled  the brainstem, by a 
v e r t ic a l  cut in f ro n t  of the an te r io r  c o l l i c u l i  (Dickerson, e t  a l . ,  1972). 
The parts of the brain were weighed and analysed immediately or stored at
-50°C. The dissection procedure is shown in F ig . 2 .1 .
®  O
Fig . 2 .1 .  Diagram of dissection procedure fo r  the r a t  bra in . Dotted lines  
ind ica te  the sections.
(c) Extractloh.' of' tryptophan,’ 5-HT' and 5-HIAA from single sample of ■
b ra in 're g io n s . '
Tryptophan, 5-HT and 5-HIAA were extracted from each ind iv idual  
brain region, as described by Knott and Curzon (1974).
The 5-HT and 5-HIAA were measured f lu o ro m e tr ic a l ly ,  according to the 
method o f Curzon and Green (1970) and the tryptophan was estimated on a 
sample o f  the ex trac t  containing 5-HT, by the method of Denckla and Dewey (1967),  
as modified by Bloxam and Warren (1974). The extraction  was carr ied  out 
as fo l lo w s :-  Tissue samples weighing less than 300 mg were homogenised 
in 3 .0  ml of cold a c id i f ie d  butanol, using a var iab le  speed homogeniser 
in a 10 ml glass homogeniser tube. (T r i-R  Instrument -  Cambridge Laboratory).
For samples weighing more than 300 mg, the homogenisation was. carr ied  out 
in 10 volumes of the a c id i f ie d  n-butanol. A fte r  cen tr ifug a tion  fo r  
5 minutes at 3,000 rpm, 2 .5  ml of the supernatant of the butanol phase 
was transferred  to a 15 ml glass stoppered tube and shaken mechanically  
fo r  5 minutes with 5 ml n-h.eptane and 1.0 ml 0.1N HC1 containing 0.1%
L-cyste ine. The aqueous phases were separated by cen tr ifug ation  fo r  
5 minutes at 3,000 rpm, fo r  the determination o f tryptophan and o f 5-HT.
The remainder of the organic phase was used fo r  the 5-HIAA determ ination..
(d) Determination, o f  5-HT. and. 5-HIAA .
As described by Curzon and Green (1970), the method is rapid and 
sens it ive  and i t  is  possible to measure 5-H.T and 5-HIAA in a s ing le  sample 
of r a t  brain by using 0-p.hthaldehyde (OPT) and L-cysteine. The s e n s i t iv i t y  
of OPT to form fluorescent.complexes with indoles in acid solution is  
improved about 4 - fo ld  by adding L-cysteine. The 5-HT and 5-HIAA may be 
determined in about 30mg of brain t issue and as l i t t l e  as 0.01 jug of 5-HT 
or 5-H.IAA may be measured. The standard curve of 5-HT and of 5-HIAA
covered the range o f 0.01 -  2 .5  yg/ml. Both 5-HT and 5-HIAA could be
determined in 18 r a t  brains or parts of the bra ins, a f te r  removal and
separation, in a period of 25 hours.
( i )  Determination of 5-HT
The solutions were a l l  prepared itrcnediately before use. Samples of 
the aqueous phase (0 .1  ml) were p ipetted into  12X 0.75cm stoppered tubes 
and 0 .6  ml of 0.004% OPT in 10N HC1 was added. A fte r  mixing with a Rota
mixer and heating in a bo iling  waterbath fo r  15 minutes, the tubes were
cooled in water and the fluorescence measured in micro-c.uvettes of 0 .3  ml 
using a Perkin-Elmer spectro fluorim eter. Activation  and emmission were 
360 nm and 470 nm respective ly . The standard stock solution of 5-HT 
(lOOng/ml) was d i lu ted  1: 100 fo r  use with 0 . IN HC1 containing 0.1% 
L-cysteine. A blank was prepared by reacting 0.6ml o f the OPT solution  
with 0.1 ml of 0.1N HC1 containing 0.1% L-cysteine only. This reag e n t• 
blank gave the same reading as t issue blanks, prepared by reacting  0.1 ml 
of the samples with 0 .6  ml ION HC1. The standard curve fo r  5-HT is  
shown on F ig . 2 .2 .
( i i ) Determination of 5-HIAA.
The organic phase (6 ml) remaining a f te r  the extrac tion  of 5-HT was 
t ransferred  to a 15 ml glass stoppered tube containing 0 .3  ml of 
0.01N HC1, shaken fo r  3 minutes and centrifuged at 3,000 rpm fo r  5 
minutes to e lim inate  the in terference by 5-HT found in the 5-HIAA 
determination (lug 5-HT caused an e rro r  of -  .8% in the determination  
of 0 .2 5 g 5-HIAA). The organic phase (5ml) was fu r th e r  extracted by 
t ra n s fe rr in g  i t  to a 1.5ml stoppered tube containing 0.6ml of 0.5M 
phosphate b u ffe r  pH 7 .0 .  The mixture was shaken mechanically f o r  
10 minutes. A f te r  cen tr ifug ing  fo r  3 minutes at 3,000 rpm, 0.2ml
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Fig. 2 .2 .  Standard curve f o r  5-HT.
portions o f the aqueous phase were p ipetted in to  te s t  tubes, A and B 
respec tive ly . To tube A, 0.02ml o f  1% L -cyte ine solution was added and 
to tube B, 0.02ml of 0.02% sodium periodate so lution . Concentrated HC1 
(0.4ml) was then added to both A and B. Subsequently, 0.02ml of 0.1% OPT 
in methanol and 0.02ml sodium periodate solutions were added to tube A. 
A fte r  30 minutes 0.02ml o f the cysteine and OPT solution were added to  
the tube B. The tubes were then placed in a b o il in g  water bath fo r  10 
minutes, cooled in water and were read at an ac t iva t io n  wavelength of 
360 nm and an emmission wavelength of 470 nm. The blank reading (tube B) 
was substracted from the te s t  reading (tube A). I t  was found th a t  the  
blank was usually  the same fo r  a l l  parts o f brain as th a t  found with  
standard so lu tion . The standard stock solution (15ug/ml) was d ilu ted  
1:100 in phosphate bu ffe r  and 0.2ml was added to tubes A and ,B. The 
standard curve fo r  5-H.IAA is shown on F i g . 2 .3 .
(e) Determination of.' tryptophan
The fluordm etric  method fo r  the assay of tryptophan (Bloxam &
Warren, 1974) involved the formation o f the fluorophore, by heating the  
tryptophan in acid (10% TCA) and fu r th e r  condensation in formaldehyde 
with subsequent oxidation in f e r r i c  ch loride . The method was simple and . 
permitted 60 determinations to be carried  out per day, and i t s  
s e n s i t iv i t y  allowed the measurement to cover the range of 0 .04 to 20 n 
moles (= 8 X 1 0 ? * -  0.4yg) tryptophan in standard 1cm2 quartz cuvettes.
The s p e c i f ic i ty  of the assay was th a t ,  of the compounds tes ted , only  
tryptamine produced appreciable fluorescence; about one-tenth of the 
molar fluorescence of tryptophan. The fluorophore produced in the assay 
solutions was stable fo r  one week and a i l  reagents fo r  at leas t  2 months.
I t  was necessary to soak the glassware in concentrated n i t r i c  acid
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Fig. 2 .3 .  Standard curve fo r  5-HIAA.
overnight once a week to remove traces of metals, esp ec ia lly  molybdenum, 
which could t o t a l l y  in h ib i t  the reaction in very low concentrations.
To determine the concentration of to ta l  tryptophan in plasma,
50yl plasma samples were deproteinised by adding 2 .0  ml of ice cold 
10% (w/v) TCA and centrifuged a t 4°C to remove the p rec ip ita ted  pro te in .
The 200ul u l t r a f i l t r a t e  of plasma samples fo r  determination of f re e  
tryptophan was trea ted  in the same way as the plasma samples fo r  the 
assay of to ta l  tryptophan. .
The tryptophan in  parts of the brain was estimated in 200 yl sample 
of the ex trac t  containing 5-HT (Knott & Curzon, 1974) according to the  
same method as th a t  used fo r  plasma tryptophan.
To each p ro te in -f re e  sample,standard or blank cooled on ice was
added 0.2ml of 2.0% (w/v) formaldehyde. Immediately, before tra n s fe rr in g
each tube to the b o il in g  water bath, 0.1 ml of 6 .0  X 10” FeClg in 10%
TCA was rap id ly  added and mixed. The time between the depro te in isation
of samples and the tra n s fe r  to the bo iling  water bath should be less than
90 minutes. A f te r  heating at a temperature of not less than 99°C, the
samples and standard were cooled and the volume were brought to 3ml in
graduated tubes. The fluorescence was measured using Perkin-Elmer spectro-
f lu o rim e te r  at an exc ita t io n  and emmission wavelength of 373 nm and
2
452 nm' respec tive ly  in 1cm quartz cuvettes. The standard curve fo r  
the determination of tryptophan is shown in F i g . 2 .4 .
( f ) Determination of.' non-esterififed- fa t ty :  acids (NEFA): in' plasma '
Test-combination-of NEFA, according to the method of Duncombe (1964 ),  
was based on the conversion of the NEFA to chloroform-soluble copper sa lts  
which were subsequently measured c o lo r im e tr ic a l ly .  The concentration of
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Fig.  2 .4 .  Standard curve fo r  determination of tryptophan.
NEFA was proportional to the  absorbance of the copper in the chloroform. 
The determination k i t  was obtained from Boeringer Mannheim (GmbH) Diagnostic 
This k i t  contained ready-made b u ffe r /cu p r ic  n i t r a te  (so lu tion  1) and 
diethyld ith iocarbam ate (so lu tion  2 ) .  The solutions were used undiluted  
and were stored in t ig h t l y  closed b o tt le s .  The s t a b i l i t y  o f the solutions  
was specified  to the expiring date when stored at room temperature 
(15°C -  25°C). Since the concentration o f NEFA in serum is  influenced  
by various fa c to rs ,  fresh plasma was co llected  under conditions as nearly  
standardised as possib le. Haemolysed plasma was avoided.
In to  10ml glass stoppered tubes the fo llow ing substances were 
pipetted:
Blank.. Standard. . Sample.'.
Chloroform ml. 5 .0  5 .0  5 .0
Standard.0 .5  mM/1. " . -  0 .2  -
PIasma " . -  . -  . 0 . 2
D is t i l le d  Water " 0 .2  -  . -
Solution 1. "  1 .0 1.0 1.0
The mixture was then shaken vigorously fo r  10 minutes using a 
mechanical shaker and was then centrifuged fo r  5 minutes. The aqueous 
layer was c a re fu l ly  drawn o f f ,  together with the p re c ip i ta te  layer ,  by 
using a f in e -t ip p e d  p ip e tte  connected to a water asp ira to r .  The 3ml 
chloroform layer was p ipetted  in to  te s t  tubes and 0.3ml so lution  2 was 
added and mixed w e l l .  A fte r  10 minutes, the absorbances o f samples 
and standard were read against the blank at 436 nm, using a Cecil 
spectrophotometer in a 1cm l ig h t  path cuvette.
The normal value of .NEFA. in. serum is w ith in  the range of 0 .09 -  ,
0 .6  mM/1. (Howorth, e t ’ a ! . / , '  1966). I f  the concentration o f  NEFA exceeds
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Fig. 2 .5 .  Standard curve f o r  NEFA.
2.0 mM/1 plasma, the assay, should be repeated with 0.1 ml sample.
The standard curve fo r  NEFA is shown on F i g . 2 .5 .
(g) Determination' of; free; amino' acids' in' plasma' .
The q u a n ti ta t iv e  separation of amino acids in the plasma, using
an amino acids autoanalyser (LKB Biochrom L im ited ),  was based on the
method of Moore and Stein (Spackman, e t  a ! . ,  1958). The amino acids 
were separated on a cation exchange resin with buffers of c a re fu l ly  
defined s a l t  concentration and pH. Depending on the amino acids present 
in the  sample, e i th e r  sodium or l ith iu m  sa lts  were used fo r  the b u ffe r  
preparations. The e luate  from the ion exchange column was passed through a te flon  
coil which was placed in a b o il in g  water bath. Before entering the c o i l *  
the column e f f lu e n t  was mixed with an acetate b u ffe r  containing reduced 
ninhydrin. This compound reacts with the amino acids to form a dye- 
complex. The absorption was determined in a.flow-p.hotometer and reg is tered  
on the chart of a recorder. The evaluation o f the amounts o f amino acids 
present in the sample was carr ied  out by ca lcu la t in g  the area under the  
peak by means of m ultip ly ing  the net height with number of dots.
The value was expressed as
chart scale x dot numbers.
(Log graph paper was used).
The log ca lcu la t io n  was as
fo llow s: H was the highest
of the peak by subtracting
the peak height and the
baseline. The h a l f  height
H ‘was calculated as ^  + base line .
The number o f dots above the  
h a l f  height was then counted (W).
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Thus the area was obtained by m ultip ly ing  H x W. Sample preparation:  
standard c a l ib ra t io n  mixture of hydrolysate amino acids was d i lu ted  (1 : 25) 
in 3% 5 -su lp h o s a licy l ic  acid (= 100 nm/ml) and was in jected  into the auto­
analyser (1 .3  m is). The peaiks of the standard c a l ib ra t io n  m ixture, as on 
Fig. 2 .5 .
The plasma sample (0 .35  ml) was d ilu ted  (1 :5 )  in 3% 5 -su lp h o sa licy lic  
acid, and was then centrifuged at 10,000 rpm fo r  10 minutes a t 4°C. A 1.3 ml 
portion o f the c lea r  supernatant was loaded d i r e c t ly  onto the column.
(h) Determination, o f  soluble enzyme tryptophan-hydroxylase a c t iv i ty ,  in
the brain regions
The .a c t iv i ty  o f tryptophan-5-hydroxylase was determined, as described 
by Gal and Patterson (1973). The method was s l ig h t ly  modified by using 
the method, as described by Curzon and Green (1970) fo r  the estimation o f  
5-HT product. The procedures were carried  out in a cold-environment ( 4 ° -  6°C ).
The brain samples were homogenised 1:3 (w/v) in 0.05 M t r is -a c e ta te
. _  3
b u ffe r  pH 7.6 containing 10 M 2-m.ercaptoethanol.. The homogenate was then 
centrifuged in a MSE superspeed 50 centr ifuge at 30,000 rpm fo r  30 minutes 
at 4°C and the crude supernatant was used as the source o f soluble enzyme.
The soluble prote in  content was determined spectrophotom etrically using a 
s l ig h t ly  modified method o f Lowry, et a ! . ,  (1951) with bovine serum 
albumin as the standard.
One ml o f  incubation mixture contained 50yM t r is -a c e ta te  pH 7 .6 ,  
lyM 2-mercaptoethanol, 0.2yM pargyline hydrochloride (N-benzyl-N-methyl-  
2-propynylamine from Aldrich Company), 10yg (p ro te in )  cata lase , subsequently 
0.1 ml of the supernatant of the enzyme prote in  and 0.46UM DMPH* 
(2-amino-4-hydroxy-6, 7 -d im ethy l-5 , 6, 7, 8 -te trah y d ro p ter id in e  from
Aldrich Company). The mixture was incubated in 5ml graduated tube by 
shaking in a i r  fo r  30 minutes at 37°C in a water bath. The reaction was 
stopped by immersing the tube in b o il in g  water f o r  5 minutes. I f  the 
volume was less than 1 ml, i t  was brought to the volume p r io r  to b o ilin g  
the sample. The denatured protein  was removed by cen tr ifug a tion  at 3,000 rpm 
fo r  15 minutes, and 0.1 ml of the supernatant was transferred  to a 
12 X 0.75 cm stoppered tube containing 0.1 ml o f 0.1% L-cysteine so lu tion .
The sample was thoroughly mixed with 0 .6  ml of 0.04% OPT in 10N HC1.
(The OPT solution was f re s h ly  prepared each t im e).  The reaction mixture  
was then heated in b o il in g  water fo r  15 minutes and cooled in tap water.
The fluorescence was measured at the ac t iva t io n  and emmission of 360 nm and
470 nm respective ly  in 0 .3  ml m icro-cuvettes, using a Perkin-Elmer spectro- 
f lu o r im e te r .  To correct fo r  the endogenous 5-hydroxyindoles, a sample of
the enzyme protein  was incubated without substrate. The 5-HT standard o f
lyg/ml contained 0.01% L-ascorbic acid and a blank without the enzyme were 
carried  through the e n t ire  procedure. The production of 5-HT was expressed 
in nanomole/mg prote in /hour.
For determination of the k in e t ic  parameters (apparent Km, V max.) o f  
tryptophan hydroxylase fo r  tryptophan, 0.46 mM DMPH* and a concentration  
of tryptophan varied between 0.1 -  4 mM was added in the incubation mixture  
(Fig.2.7). Conversely, the concentration of tryptophan was maintained at
1.0 mM and the DMPH«. varied between 0.23  and 1.38 mM (F ig 2 -8 ) ,  to estimate  
the V max and the apparent Km of tryptophan fo r  i t s  cofactor. The 
standard curves fo r  5-H.T concentration in incubated reactions, w ithout  
enzyme and with enzyme are shown in F ig .2 .9 .
2-Mercaptoethanol maintains the cofactor in a reduced form ajrd 
also appears to be required by the enzyme fo r  the optimal a c t i v i t y ,
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(Sjoerdsma, et; al/. , 1970). Pargyline was also required in the determination  
of 5-HT product as th is  compound in h ib its  the MAO a c t iv i t y .
( i ) Determination o f  soluble p ro te in ' in  the' brain;
The protein concentration in 30,000 rpm supernatant o f enzyme 
protein fo r  tryptophan hydroxylase was determined using a m odification  
of the method described by Lowry, e t  a ] . , (1951). The supernatant (50y l)
. was d ilu ted  to 2.5m1 with d i s t i l l e d  water, and 0.25ml of the d i lu t io n  
was then transferred  fo r  the prote in  estimation.
The reagents required were as fo l lo w s :-  (A) 2.0% (w /v )-.
Na2C03in 0.1 N NaOH; (B) 2.0% (w/v) NaK t a r t r a te ;  (C) 1%(w/v)
CuSOi, 5 H2O.; (D) Fo lin  and C io ca lteu ’ s reagent (Sigma).
One ml of each of reagents B and C were mixed immediately p r io r  to 
use with 100 ml o f reagent A,and 2.5 ml of the mixture was added to the  
0.25 ml of d ilu ted  protein  so lu tion . A fte r  mixing and standing fo r  
10 minutes, 0 .5 ml of reagent D (1:1 d i lu t io n )  was added and the solutions  
were mixed thoroughly. A f te r  allowing to stand at room temperature fo r  
30 minutes the o p tica l density was read at 720 nm in a Cecil spectrophoto­
meter. A blank o f d i s t i l l e d  water was used, together with 2 .5  ml 
standards containing a d i f fe r e n t  concentrations (between 50 -  500yg/m1)of serum 
bovine albumin. The standard curve fo r  albumin is shown in F ig .2.10 .
( j )  Recovery studies on the analyses .
Recoveries were determined by the addition of known amount of  
standards to extracts  of samples and were carr ied  through the e n t ire  
procedures. Recoveries of the standards added to samples ( in te rn a l  
standards) were calcu lated  and the resu lts  were expressed in percentages,
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according to the fo llow ing form ula:-
R ■ 1 X 100%Recovery = . ^
R = concentration of sample added with in te rna l standard
T = concentration of sample
S = concentration of the known in te rn a l standard added.
The recoveries of the in te rn a l standards added to samples fo r  various
analyses, as shown on Table 2 .2 .
Table 2 .2 .  Recoveries o f in te rna l standards added to samples
Mean ± s.e.m.
Tryptophan
Total plasma 101 ± 11
Free plasma 79 ± 9
Forebrain 80 ± 5
Cerebellum 65 ± 6
Brainstem 80 ± 6
5-HT
Forebrain 60 ± 5
Cerebellum 65 ± 7
Brainstem 70 ± 7
5-HIAA
Forebrain 80 ± 7
Cerebellum 75 ± 3
Brainstem 80 ± 9
Plasma NEFA 103 ± 12
Recoveries are given as a percentage of values fo r  in te rn a l standards 
carried  through the methods and are means ± s.e.m. of ten determinations.
(k) Observations'on interfemale^behaviour of adult'rats:
The observations on the type of behaviour shown by the presence 
of a female ra t,  to which the partner has not become accustomed, 
was carr ied  out at in te rv a ls  o f  seven days fo r  35 days. The tes t in g  
was performed during the evening (7 pm -  9 pm) since the r a t  is usually  
highly  ac tive  at th is  time. The tes t ing  took place in a qu ie t room 
under minimal l ig h t in g  in the Animal Un it. P r io r  to in troduction , a 
weight-matched control was selected fo r  each experimental, animal dosed 
with n ic o t in ic  acid, tryptophan and in s u l in .  The te s t  took place in a 
1idless p ia s t ic  community cage measuring 24 X 12 X 6 inches. Before 
each te s t  the inside o f the cage was swabbed with d ilu ted  'Decon* to 
minimise the e f fe c t  of residual smell from animals used in previous 
tests  (Brain & Nowell, 1970), because i t  is  suspected tha t th is  influences  
behaviour in rodents.
The control ra t  was placed in the observation cage and was allowed 
5 minutes to become accustomed to the environment before the experimental 
animal was introduced.. The experimental ra t  was id e n t i f ie d  by a marker 
on i ts  fu r .  The behaviour of each p a ir  was observed fo r  10 minutes.
The code word of each a c t iv i t y  performed by both ra ts  was noted. A f te r  
10 minutes' observation, the rat's were returned to th e i r  respective cages 
and the observation cage cleaned fo r  the next p a ir .  Five pairs  were 
tested on each occassion.
The a c t iv i t i e s  were c la s s i f ie d  in to  categories adapted from those 
used by Grant and Mackintosh (1963). Behaviour was divided into non­
social behaviour, social behaviour, sexual behaviour, offensive and 
defensive behaviour. The d i f fe r e n t  kinds of behaviour performed are 
shown in Table 2 .3 .
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(1) Observations on' the' physical 'Activity' of adult' ffemale- rats.'
The a c t iv i t y  of the ind iv idual animal in each group was measured 
at weekly in te rv a ls  in an a c t iv i t y  meter, equipped with an a c t iv i t y  
wheel measuring 16" d ia . X 15" in h" s tra ig h t  mesh. The cage attached 
to the wheel was f i t t e d  with a removable food hopper and recess fo r  a 
water b o t t le .  As with those fo r  the behavioural experiments, a control
animal was paired by weight with an experimental animal and placed
separately into  the a c t iv i t y  wheel fo r  24 hours. The a c t i v i t y  score 
was monitored on the speed counter f i t t e d  to the wheel support. Five  
pairs o f  animals were tested per week.
(m) S ta t i  s .t ica l. eva.luations .
Most of the resu lts  were expressed as means -  s.e.m. and the groups 
were compared by means o f Student‘ s t-test. Correlation c o e ff ic ie n ts  and
regression l ines  fo r  associated data were performed, where appropriate.
: 2
The behaviour data was subjected to Chi-square d is tr ib u t io n  (X ) by calcul 
t in g  the to ta l  number of a c t iv i t i e s  in each category fo r  each group.
A o n e -ta i led  F - te s t  fo r  variance ra t io  was applied to evaluate the  
a c t iv i t y  scores and food in take, followed by comparison of the d iffe rence  
between means of the groups.
CHAPTER 3
EFFECTS OF THE COMBINED ADMINISTRATION OF 
NICOTINIC ACID, INSULIN AND TRYPTOPHAN ON 
THE CONCENTRATIONS OF TRYPTOPHAN AND ITS 
METABOLITES IN BRAIN REGIONS. '
INTRODUCTION
There is  some evidence th a t  the metabolism of brain amines may be 
disturbed in some kinds of depression and possibly in mania (Murphy, 
e t a l . , 1978) and th a t  a defect in serotonin (5-HT) synthesis may be 
involved (Coppen, 1967; Lapin & Oxenkrug, 1969). Indeed, low levels  
of 5-HT (Shaw, e t  a l . ,  1967) and i t s  m etabolite , 5-HIAA (Bourne, e t  a l '.,
1968) were found in the hindbrain o f depressive suicides. I t  has also 
been reported th a t  women with depressive symptom have reduced concentra­
tions o f f re e ,  but not t o t a l ,  tryptophan in the plasma (Coppen. et a l . ,  1973).
Accordingly, attempts have been made to t r e a t  depression associated 
with low levels  of 5-HT by administering i ts  precursor, tryptophan 
(Coppen, e t  a l .., 1967) which has been thought to increase the amount of 
5-HT at synapses and thus possibly produce c l in ic a l  b e n e fit  (Growdon, 
e t a l . ,  1977). However, claims th a t  L-tryptophan alone may be e f fe c t iv e  
as an antidepressant remain equivocal (Bower, 1970; Mendels, e t  a l . ,  1975).
I t  has been claimed th a t  L-tryptophan f a i l s  to e x h ib it  s ig n i f ic a n t  a n t i -  
depressant properties in severely i l l  patients (Murphy,et a l . ,  1974;
Farkas, et a l . ,  1976). However, the administration of 5 grammes 
L-tryptophan per day (corresponding to + 60 mg/kg) may cause a remission 
of depression in about 2 weeks in newly admitted patients  (Winston, 1975).
The adm inistration of higher doses (up to 8 g/day) of L-tryptophan has 
been found not to be e f fe c t iv e  as the lower doses (Herrington, 1974).
Green, (1978) has reported tha t an oral tryptophan load (50 mg/kg) in 
depressives produced a 7-f.old increase in to ta l  tryptophan le v e ls  in 
the plasma.
Studies in ra ts  have shown th a t  the concentration of 5-HT and 
i ts  m etabolite , 5-HIAA, in the brain rises in response to an e levation
of brain tryptophan a f te r  fo llow ing the in trap erito n ea l in je c t io n  of 
L-tryptophan-(12 .5  -  .25 mg/kg) (Wurtman & Fernstrom, 1972; Yuwiler, 1973; 
Knott & Curzon, 1974). Further studies (Wurtman & Fernstrom, 1975) 
have shown tha t  la rger  doses of L-tryptophan (50 mg/kg) re s u lt  in no 
fu r th e r  increment in brain 5-HT. Curzon, e t  a l . , (1 9 7 8 )  have also shown 
tha t when ra ts  are given a s t i l l  higher dose o f L-tryptophan (100 mg/kg), 
the r is e  in the concentration of brain 5-HT is smaller than o f 5-H.IAA.
Since n ic o t in ic  acid has been shown to be a useful pharmacological 
tool in research on a f fe c t iv e  disorders (H o tte r ,  1973, Curzon & Knott, 1975), 
i t .h a s  been suggested th a t  a combination of tryptophan and n ic o t in ic  acid 
might be superior to treatment with e i th e r  tryptophan or n ic o t in ic  acid 
alone. MacSweeney (1975) has suggested that in patients a dose of 3 grammes 
of L-t.ryptophan per day (corresponding to less than 50 mg/kg) may be e f fe c t ­
ive as an antidepressant i f  combined with nicotinamide. This has been 
supported by the f ind ings (Chouinard, et a l . ;  1977) tha t combined 
tryptophan-n.icotinamide treatment resu lts  in increased plasma concentra­
tions- of f re e  and to ta l  tryptophan, as well as in improvement of th e i r  
depression ra t in g  score.
Furthermore, Curzon and Knott (1974) have reported th a t  changes in 
plasma and brain tryptophan in male ra ts  occur on adm inistration of  
n ic o t in ic  acid and in s u l in .
In one of the experimental studies were determinations made o f the 
e f fe c t  of tryptophan on 5-H.T or 5-H.IAA in d i f f e r e n t  parts of the b ra in .  
Moreover, tryptophan was administered by in trap er ito n ea l in je c t io n ,  
ra ther  than o r a l ly ,  as is  the manner of i t s  adm inistration in the human.
In add it ion , the studies, were mostly carr ied  out on male ra ts  whereas 
depression is  more common in females. I t  therefore  seemed worthwhile  
to study the e f fe c t  o f the adm inistration o f tryptophan with and without
both n ic o t in ic  acid and in su lin  on brain tryptophan m etabolites.
Since the entry  o f  tryptophan in to  the brain may be affected by 
the concentrations of other neutral amino acids as well as th a t  of 
tryptophan (Wurtman & Fernstrom, 1972) and possibly also by the plasma 
concentration of NEFA (Curzon, e t  a.i..., 1973) i t  seemed worthwhile to  
study these also.
MATERIALS AND METHODS
Dosing -  protocol
Ten groups of female adu lt W istar Albino ra ts ,  each of 5 animals and 
weighing 180 -  .220 grammes, were caged in d iv id u a lly  and fed the normal 
d ie t  in a powder form. The groups were assigned to d i f fe r e n t  dosing
regimens, as fo llow s:
Group Treatment Saline
( i . p . )
D i s t i 11ed 
water
(o ra l)
N ico tin ic  
acid 
(60 mg/kg) 
(o ra l)
Tryptophan
(50 mg/kg) 
(o ra l )
Insu lin
2 I .U . /k g  
( i . p . )
1 Water (co n tro l) 2 mis
2 N ico tin ic  acid 2 mis
3 N ico tin ic  acid 
and sa line 0.1 mis 2 mis
4 - N ico tin ic  acid 
and insu lin 2 mis 0.1 mis
5 Saline and 
water (co n tro l) 0.1 mis 2 mis
6 Tryptophan 0.1 mis 2 mis
7 Insu lin 2 mis 0.1 mis
8 Tryptophan and 
insu lin 2 mis 0.1 mis
9 N ico tin ic  acid 
tryptophan 0.1 mis 2 rnl s
10 N ico tin ic  acid & 
tryptophan 
and in su lin 2 mis 0.1 mis
The adm inistration of tryptophan, n ic o t in ic  acid and in su lin  was 
described, as in Chapter 2.
The doses were given d a i ly  fo r  35 days and during th is  time the 
animals were weighed weekly. At the end o f  the experiment the animals 
were proceeded, as previously described in Chapter 2 . The removal 
and dissection o f the brain was carr ied  out, as described in Chapter 2 .
Biochemical procedure
Tryptophan, serotonin (5-HT) and 5-hydroxyindole-acetic  acid 
(5-HIAA), were extracted from each ind iv idual brain region and determined, 
as previously described (Chapter 2 ) .  .
Plasma was not frozen before preparation of the u l t r a - f i l t r a t e  fo r  
the  determination of f re e  tryptophan (Chapter 2 ) .
Plasma n o n -es te r if ied  f a t t y  acids were determined c o lo r im e tr ic a l ly  
using a k i t  of test-combinations of non -es te r if ied  f a t t y  acids.
(Boehringer -  Mannheim)..
The concentration o f amino acids in the plasma were determined with  
an LKB amino acid autoanalyser.
RESULTS
1. E ffec t  on the body weight
Tables 3.1 and 3.2 show th a t  ne ither  n ic o t in ic  acid alone, nor
when with in su lin  and tryptophan, had a s ig n i f ic a n t  e f fe c t  upon the
body weight of ra ts .
2. E ffe c t  on the brain weight
The adm inistration of n ic o t in ic  acid and insu lin  had no e f fe c t  on 
the brain weight (Table 3 .3 ) ,  but when tryptophan, e i th e r  alone or with
- u » / _
CD
03
S -
CD
4->
s z
CD
03
> >
"O
oJQ
<u
s z
4->
c
o
ID
c
* o
c
•03
o
03
a
•r—C
•r—
+->
o
a
4—O
o
cu
4-4-LU
CO
03
SZ
03
C lcs
ot - '
CD
O
03
CD
03
E
C
03
CD>
S-
o
4-
CD
c
0303
E
4- 
O
S_
o
5-
s_
CD
“O
s-03T3
COS
4->
CD
+ I
CD
C03
CD
a)
s-
03
CD
03
Z3
03
CO
O CO
LOto
+ 1
CO
CM
LO
CM
LO
CM CM
CO O
COCO 
co 
+ !
COCM
+ I
CM
CO
CMCM CM CM
CO
O
CO
CO
CO
OCD
COCO CO
CD
CO
CO
CM
CM
CO
CM
CMCM
VO
vo
vo
LO
00
+1
CD
CM
+ ICD CM
O
CM
CM
CO
CM
CM
O
CM
CM
O
CD
O
COO
*3- co LO
00
O
CM
O
CMCM
00 00CO
LO
LO LO.• <o
CD
O
CM
COO
O
CM
O
CM
CD
-o * o
T> *o* o
+J
4->
C  * r -
4->
O  CD O C
Ta
bl
e 
3.
2.
 
Ef
fe
ct
 
of 
tr
yp
to
ph
an
, 
ni
co
ti
ni
c 
ac
id
 
an
d 
in
su
lin
 
an
d 
th
ei
r 
co
m
bi
na
tio
ns
 
on 
th
e 
bo
dy
 
w
ei
gh
t 
(g
ra
m
m
es
)
-8 4 -
CM 1— CO p^ p*. LO
i— 00 o CO O
* • • • -•
lo CO Pv LO. LO O  :
<u
a) uo + 1 +  i +  1 +  1 +  1 +  «
3 : .
LO CO 05 CO LO CO
LO LO d * LO d" LO
CM CM CM CM CM CM
,__ p^ p-» LO P^ LO
r— CO CM O CO 00
« • • . « * •
o . CO. d -. 05 CO CM
aj
<u d - +  1 + 1 +  • +  1 + 1 +  1. 3 :
Q . r — o r>» CO p^ 05
3 d - . d - co d - CO d -
O CM CM CM CM CM CM
c
05
05 LO CO CM d" d v
s z O 05 r— CM ' O p^
o • • « • • •
rd o . CO d - d-. CO CM.
<u CD
CD CO + 1 + 1 +  i +  i +  1 +  1
e 12
•1“ LO LO CO O LO CO
CO CO CO d - CO d -
1/5 CM CM CM CM CM CM
fd
e 05 LO CO CO LO d -
•r— i— CM LO o CO O
e • • • « • •
fd d \ LO Pv d". LO. o
CD
a> CD CM +  I +  I +  1 +  1 +  1 + 1
> 3 :
•r— «vj- CO O d* i— 05
4 - CM CM CM CM CM CM
CM CM CM CM CM CM
s_
O
4 - 05 LO CO LO d * CO
O i— O CM • r— O
l/> • « • • • •
E CO d -. CO d* LO o .
fd CD
cd CD v— + 1 +  i + 1 +  I +  1 + 1
e 3 :
d" d - (— CM CM LO
4 - r— r - 1— r~ r~ r—
O CM CM CM CM CM CM
s-
o r~“ 05 05 Pv LO LO
s- r— O O O O O
s- i— -P • • • • • •
CD cd _c r— CM co CM CM CM.
•i— CO
XJ -P  -r- +  1 +  1 +  i +  1 +  1 +  1
S- •r- CD
fd E  3 LO d - d - CO d * d -
-o 1—1 CO CO CO CO CO CO
c r— 1---■ r—* 1— I--- r—
fd -
-P
IS)
f  1
CO
e c
<d •r~
CD r“*
E 3 XJ
m c
c fd
• . CD •r—
(D E X3 XJ
S- •r— XJ XJ ■«- XJ *r-
fd r— c e  o c  o
fd fd fd fd fd fd
1/5 to
a) c e c  o c  o
=3 -p X ) r— fd fd fd •!— fd *r—
i— E e  o s z s z s z  e SZ E C
fd CD fd  s - CL e CL CL*f— Q_*r— •r—
> E •p o •1— O O  -P O -P  r—
■P E  c -p r— -P ■P o -P  O  3
fd CD O CL 3 a . cl a C l o  m
CD -P O >5 m >> >5 *r— >>*r- E
S- fd — S- cz s- S- c S- E  •«-\— 3 1— i—i y— h - h -
r*-.. x—
O ■ o  ■ O o
E-
3 o o o
•
o
+1 +  1 +1 + 1
CD E£ r— o VO LOJJ
0) CD CO CO CM CM
£
cu o o O O
o
CM CO CM
O o O O
E • • • •
CU o o o o
P- P
3 to +  1 +  1 +  1 +  1
O E
£ £ £ LO CD CD CD
CD •I— CD . LO LO LO LO
fd • • • •
• SZ £ o o o O
p o CQ
s z fd
CD <D
•i—
CU £
•i—
£ to CM CM CM CO
•r- r— O O O o
fd fd £ • • • •
£ E •i— o o o o
X) •r— fd
£ £ +  1 +  1 + 1 +  1
CU fd XI E
-C cu £ CO o CO
P LO £ CD i— r— o o
o . • • • •
£ £ Ll- r— r— 1— r —
o o
4-
£
•r- to
r - £
3 fd(/J CD£ E
•r~ r-“ CO
4- o o o o
*o O • • • •
£ o o o o
fd CU£ i— E + 1 + 1 + 1 + 1
XJ o o £•p- £ J£ CD CD CM CM
O £ 3= - CD CD CD CD
CCS cu ■ • • • •i r — r - i
o xj
•r— £
£ CCS
•r“ XJ
P £
o CCS
o -p
•r— to
£ XJ XJ
+ 1 £ £4- fd CCS
O to c
£ -P r ~ XJ XJ cu -o •«-
P fd £ o •1“ •i- £ •r— i—
O ni CU £ o O •!- C_) 3
0) £ E p fd fd i— fd CO
4- 4-> £ fd £
4- fd O u o  to O -f-
L±J • • cu o •i— •t— •i—
CU £ *—^ £ £ £
CO £ 1— •r— •i— •p“
fd £ P P P
co CU O O Oto p O o O
CU cu fd • i— •r— •r-
3 3: ZZ ZZ z
XI r —
fd fd
\ - >
Ta
bl
e 
3
.4 
Ef
fe
ct
 
of 
tr
yp
to
ph
an
, 
ni
co
ti
ni
c 
ac
id
 
an
d 
in
su
lin
 
an
d 
th
ei
r 
co
m
bi
na
tio
ns
on
 
th
e 
br
ai
n 
w
ei
gh
t
E
3 . 1— -• r— r— CM r— CM
1— 0 0 0 O 0 O
r - E • • ,=• • • •
CD e 0 0 O O 0 O
JD CO
CD +  1 +  1 +  1 +  1 *  +  1 *  +  |E * *
CD CO «3- *3 * 'O' to to
O CO co CO CO CO CO
• • • • • •
0 0 0 0 0 0
E
CD CM t— t— r— CM r -
P O 0 0 O O O
CO • • • • • ■ •
• E O 0 0 O O O
JCL sz e
3 •r— co +  | +1 +  1 +  | +  1 *  +  1
O CO *
E E to 0 1— r— CO
cn CQ LO to to to to to• • • • • ' •
s z O 0 0 O O 0
0
rO
cd
e
•r—
CO e *3* to «3" CM CO LO1— >r— O 0 0 O 0 0
rd CO . • • • • • •
E E E O 0 0 O 0 0
• r— XI e
E CD co +  1 +  1 +  1 +  | ■H +  1CO E
0 O CM CO *3* r— CO
LO Ll. CM CM r— r— CM CM
• • • • - • •
S- 1— 1— 1— r— r— r—
04—
CM
to O
E •
CO O
cd
E V
LO r-^ LO LO to4- O 0 O O O 0 o_
O • • • • • •
CD O 0 O O O 0 •Jc
i—■ E •JC
E O e +  1 +  1 +  I +  1 +  1 +  1
O x : CO CD
E 3 cr> 0 •O' O CO CM U
E - 0 r— 1---- r— [---- CM E
- CL) • • « • • . • CD
CM CM CM CM CM CM E
■O CD
E 4-
CO ✓— 4-
* 0 i— •r—
e O O O X3
E •r— •r—
P P SZ SZ E p
CO SZ •1— • r — •r- E
0 1---- P P CO
+1 0 3 O O U*.—^ to O O •r™
CO SZ •r- •1-  E 4-
e CD •1— z 2 : *p- •1—
CO ■ E r— E
CD •r— XJ XJ XJ 3 CO
2 r— sz • sz E CO •1—
CO co co XJ CO E to
W •f— 1—1
• • SZ sz E O E r—
CD XJ cO co CO. cO CO XJ CO
E e J Z s z SZ jC E O
CO fO Ol SZ SZL SZl Q- CO •1—
O •1— 0 0 O P
CO e P 1— P P 4-> XJ to
(D CD O. 3 Q. CL CL-r- •1—
3 P >, to >, >> >> O P
fO e SZ e E E C CO
tO :s J— t— t h- f— I— P
> to
in s u l in ,  was given with n ic o t in ic  acid (Table 3 .4 ) there was a 
s ig n if ic a n t  ( P<0.02) r is e  in the weight of the cerebellum. In the  
animals th a t  received n ic o t in ic  acid and insu lin  with tryptophan the  
brainstem was also s ig n i f ic a n t ly  ( P<0.02) heavier than in the contro ls .
3. E ffects  on 'the tryptophan, 5-HT and of 5-HIAA
Table 3.5 shows th a t  the adm inistration of n ic o t in ic  acid , e i th e r  
alone or with in s u l in ,  had no s ig n if ic a n t  e f fe c t  on e ith e r  to ta l  or 
f re e  tryptophan in the plasma. However, n ic o t in ic  acid caused a r is e  
in the concentration of tryptophan in the brainstem ( P<0.01) and the 
cerebellum (P<0.01) but not in the fo reb ra in . Insu lin  did not fu r th e r  
increase the level of tryptophan in animals given both n ic o t in ic  acid 
and in s u l in .  Only in the brainstem was there a s ig n if ic a n t  reduction  
(P<0.05) in the level of 5-HT, whereas there were no changes due to 
the n ic o t in ic  acid and/or insu lin  in the concentration fo 5-HIAA.
Table 3.6 shows th a t  ne ither the adm inistration of tryptophan or 
insu lin  alone, nor together, s ig n i f ic a n t ly  reduced the level of to ta l  
or f re e  tryptophan in the plasma. The adm inistration of tryptophan 
with n ic o t in ic  acid also did not s ig n i f ic a n t ly  lower the plasma 
tryptophan le v e l .  However, when n ic o t in ic  acid and insu lin  were given 
with tryptophan the plasma level of to ta l  tryptophan, and p a r t ic u la r ly  
of the fre e  tryptophan, was reduced (P<0.05) with respect to the control 
and also to the group th a t  received tryptophan alone (P<0.05). The 
level of f re e  tryptophan was lower in the t re b ly - t re a te d  group than in 
those tha t  received in su lin  alone. In the forebra in  the adm inistration  
of tryptophan and in su lin  alone had no s ig n if ic a n t  e f fe c t  on the con­
centration  of tryptophan, whereas when in su lin  was given with tryptophan
the concentration was s ig n i f ic a n t ly  reduced (P<0.01 ) .  A s im ila r  ; 
reduction was found when n ic o t in ic  acid was given with tryptophan and 
there was no add itional e f fe c t  when both n ic o t in ic  acid and in su lin  
were given with tryptophan. The concentrations of tryptophan in the  
brainstem were higher than in the fo rebra in  or cerebellum. The only
s ig n if ic a n t  d iffe rence  between the concentrations in the d i f f e r e n t  groups 
was tha t  when n ic o t in ic  acid and tryptophan were given with in su lin  the 
level of tryptophan was higher than when in su lin  was given alone (P<0.05) 
In the cerebellum ne ither  the adm inistration of tryptophan or in su lin
alone s ig n i f ic a n t ly  changed the concentration of tryptophan but when 
insu lin  was given with tryptophan the concentration was s ig n i f ic a n t ly  
higher than in the control group ( P<0.01) and i t  was also higher than in 
the groups th a t  received in su lin  (P<0.01) or tryptophan alone (P<0.05 ).  
The adm inistration of n ic o t in ic  acid with tryptophan produced a s im ila r  
e f fe c t  (P<0.05) and the concentration was not increased fu r th e r  by the 
adm inistration of in su lin  with n ic o t in ic  acid and tryptophan.
The concentration of 5-HT in the forebra in  of the animals th a t  
received n ic o t in ic  acid and insu lin  with tryptophan was s ig n i f ic a n t ly  
lower than in the controls (P<0.01) and also than those th a t  received  
tryptophan alone or insu line  alone (P<0.05). There were no s ig n if ic a n t  
differences between the groups, in the concentration of 5-HT in the  
brainstem. In the cerebellum the adm inistration o f n ic o t in ic  acid 
with tryptophan produced a s ig n i f ic a n t  reduction in the concentration  
of serotonin (P<0 .0 1 ) ,  whereas the adm inistration o f in su lin  with  
tryptophan did not change the value.
Neither the adm inistration of tryptophan, nor of in su lin  alone 
resulted in any change in the concentration of 5-HIAA in the fo re b ra in ,
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however, when in su lin  was given with tryptophan the concentration of 
5-HIAA in the fo rebra in  was s ig n i f ic a n t ly  lower than e ith e r  of the 
other three groups, control (P<0.02), tryptophan (P<0.05) and 
insu lin  (P<0.01). The greatest d iffe rence  however was found in the  
group th a t  received n ic o t in ic  acid and insu lin  with tryptophan fo r  
here the concentration of 5-HIAA was s ig n i f ic a tn ly  lower than th a t  in 
any of the groups ( P<0*01) with the exception of th a t  receiving insu lin  
with tryptophan. The d ifferences in the concentration of 5-HIAA 
between the groups in the brainstem were small and bare ly  reached 
sign ificance  in any one group. In the cerebellum, however, the 
concentration of 5-HIAA was lower in. the groups receiving tryptophan : 
and in su lin  alone, compared with the control group. I t  was also lower 
in the group th a t  received tryptophan with in s u lin .  A s im ila r  re s u lt  
was obtained in the group th a t  received n ic o t in ic  acid with tryptophan 
and no fu r th e r  reduction occurred when n ic o t in ic  acid and insu lin  were 
given with tryptophan.
4. E ffects  on the concentration of neutral amino acids and of the
NEFA (non-e.sterified f a t t y  acids) in the plasma
Tables 3.7 and 3 .8  set out the concentration of neutral amino acids 
and of NEFA in the plasma of the d i f fe r e n t  groups of animals. The 
adm inistration of n ic o t in ic  acid caused a f a l l  in the concentration of 
methionine and of isoleucine which did not occur when in su lin  was also 
given (Table 3 .7 ) .  On the contrary, insu lin  resulted  in a r is e  in the 
concentration of methionine and isoleucine when compared with the 
animals given n ic o t in ic  acid alone. The adm inistration o f n ic o t in ic  
acid and insu lin  with tryptophan s ig n i f ic a n t ly  reduced the concentra­
tions of tyrosine and phenylalanine in the plasma (Table 3 .8 ) ;  however,
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i t  had no e f fe c t  on the concentrations of other neutral amino acids 
(v a l in e ,  methionine, isoleucine and leuc ine).
Neither n ic o t in ic  acid alone, nor when given with in su lin  and 
tryptophan, had a s ig n if ic a n t  e f fe c t  upon the concentration of NEFA 
in the plasma (Tables 3.7 and 3 .8 ) .
DISCUSSION
The concentration of to ta l  tryptophan in the plasma.of animals 
tha t received n ic o t in ic  acid and in su lin  with tryptophan was some 20% 
lower than the control values. The concentration of f re e  tryptophan in
the plasma was reduced by about 40%.
The changes in the concentrations of tryptophan, 5-HT and 5-HIAA 
were d i f fe r e n t  in the regions of the brain when the animals received  
d i f fe r e n t  treatments. I t  is possible th a t  due to d i f fe r e n t  fa c to rs ,  
the changes of tryptophan concentrations were determined by uptake and 
exchange of tryptophan in the d i f fe r e n t  parts of the bra in .
The concentration of tryptophan was higher in the brain stem than 
in the other regions studied.and th is  can be explained by the concentrati 
of serotonergic neurones in the hypothalamus and other regions included  
in the sample. The tryptophan level in th is  part of the brain was 
changed most by the various treatments. I t  may be th a t  the changes, 
and probably the uptake , of tryptophan in the brain stem is  more 
e f fe c t iv e  than i t  is  in other parts of the bra in . This is  in agreement 
with the data obtained by other workers who showed tha t  the uptake of 
tryptophan e i th e r  in v i t r o  (Denizeau & Sourkes, 1977), or in v iv o ,
(Knott & Curzon, 1974) a f te r  the in tra -p e r i to n e a l  in je c t io n  of tryptophan
(50 mg/kg) was higher in the hypothalamus than in other regions.
The adm inistration of n ic o t in ic  acid, e i th e r  alone or with in s u l in ,  
caused a r is e  in the leve ls  of tryptophan in the brain stem and cerebellum. 
I t  has been suggested th a t  n ic o t in ic  acid and insu lin  are both a n t i l ip o ly t ic  
agents (Butcher, e t  a ! . ,  1968) and th a t  these compounds may a f fe c t  
l ip o ly s is  v ia  th e i r  e f fe c t  on cAMP in adipose.tissue (F ig . 3 .1 ) .  The 
mechanism involves in te ra c tio n  with binding s ites  of tryptophan to albumin 
(McMenamy & Oncley, 1958) th a t  compete with plasma non -es te r if ied  f a t t y  
acids and u lt im a te ly  a f fe c t  the concentration o f tryptophan in the brain .
The adm inistration o f n ic o t in ic  acid and insu lin  with tryptophan was 
more e f fe c t iv e  in changing the concentrations o f f re e  and to ta l  tryptophan 
in the plasma than was n ic o t in ic  acid , insu lin  or tryptophan alone. The 
p o s s ib i l i t y  th a t  n ic o t in ic  acid i t s e l f  plays a ro le  in influencing the  
plasma level of insu lin  (Tasaka, et a l . ,  1976) is  supported by the f ind ings  
tha t adm inistration of n ic o t in ic  acid in man decreases the plasma concentra­
tions of NEFA ( I r i e ,  et a l . ,  1962) and of insu lin  (Balasse & Neef, 1973).
I t  was claimed that insu lin  increases the uptake of tryptophan in to  the 
brain (Dickerson & Pao, 1975^); however, Mackenzie and Trulson (1978) 
found tha t insu lin  has no d ire c t  e f fe c t  on the brain to increase the concen­
tra t io n  of the brain tryptophan.
Other plasma neutral amino acids (v a l in e ,  leucine, iso leucine,  
tyrosine and phenylalanine.(Wurtman & Fernstrom, 1972) and methionine 
(Pardridge, 1977) compete with plasma tryptophan fo r  transport in to  the 
brain . I t  is ,  there fo re , possible th a t  giving the.animals d i f fe r e n t  
treatments resulted in d i f fe r e n t  a lte ra t io n s  of concentration of the 
neutral amino acids in plasma and hence in the uptake of tryptophan into  
the b ra in . The adm inistration of n ic o t in ic  acid reduced the
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plasma concentration of methionine and iso leucine, but these changes 
were prevented by the concomitant adm inistration of in su lin  and did 
not occur when tryptophan was also given. However, the adm inistration  
of n ic o t in ic  acid and in su lin  with tryptophan s ig n i f ic a n t ly  reduced 
tyrosine and phenylalanine. I t  is  conceivable, th ere fo re , th a t  the 
a lte ra t io n s  in the c irc u la t in g  leve ls  of the neutral amino acids may 
be one of the contributory  fac tors  causing the changes of tryptophan 
concentrations in the bra in . I f  th is  were so, i t  would be expected 
th a t  the d i f f e r e n t  treatments could promote the uptake of methionine, 
iso leucine , tyros ine  and phenylalanine. I t  would be of in te re s t  to 
study the e f fe c ts  of these d i f fe r e n t  factors  on the concentrations of  
the neutral amino acids in the d i f fe r e n t  parts o f  the b ra in .
The changes in the concentration of methionine in the plasma of the
animals th a t  received n ic o t in ic  acid may cause some change in 5-HT
turnover. Methionine plays a s p e c if ic  r o le - in  the formation of methyl-
groups (~CH3) (Axelrod & Weissbach, 1961). I t  acts as a methyl-donor
in the synthesis of melatonin. The formation of a n ic o t in ic  acid 
v.
d e r iv a t iv e ,  N -methyl nicotinamide (N.-MN) also involves methylation.
I t  might be expected th a t  as melatonin and NV-MN are both methyl 
receptors they would compete fo r  methyl-groups and hence in te r fe r e  w ith  
5-HT turnover.
A decrease in concentration of isoleucine when the animals received  
n ic o t in ic  acid is  probably due to the breakdown of isoleucine to oxalo- . 
acetic  acid through. a-methyl-acetoacetyl-S-CoA, catalysed by a s p e c if ic  
NAD-dependent dehydrogenase enzyme (Bender, 1975). I t  is ,  th e re fo re ,  
possible th a t  n ic o t in ic  acid, a precursor of NAD, could accelerate  the  
breakdown of iso leucine.
The present study suggests th a t  not only is  the synthesis and degra­
dation of 5-HT in the brain influenced by the a v a i l a b i l i t y  of tryptophan 
alone (Knott & Curzon, 1972), but also tha t the metabolism of tryptophan 
is  contro lled  by d i f fe r e n t  fac to rs  which influence the uptake and 
exchange o f tryptophan and the a c t iv i t y  of the enzymes involved. Further­
more, these processes d i f f e r  in the d i f fe re n t  parts o f  the b ra in .
The present resu lts  also show th a t  the treb le -trea tm ent of n ic o t in ic  
acid with tryptophan and insu lin  appears to produce the greatest e ffe c ts  
in the d i f fe r e n t  parts of the bra in .
CHAPTER 4
LONGITUDINAL STUDY OF THE EFFECTS OF 
COMBINED TREATMENT OF NICOTINIC ACID 
AND INSULIN WITH TRYPTOPHAN ON 
SEROTONIN METABOLISM.
INTRODUCTION
In previous work the e f fe c ts  on brain indoles of d i f fe r e n t  treatments. 
(Chapter 3), or feeding a dry corn d ie t  (Fernstrom & Wurtman, 1971^), were 
studied a f te r  5 weeks treatment. No information was obtained about the 
time-course of the changes in brain tryptophan and 5-HT. Zambotti, e t  al,. ,  
1975) provided evidence th a t  when adult ra ts  were fed a corn d ie t  fo r  
2 to 20 days, there was a gradual f a l l  with time in the concentrations of 
tryptophan, 5-HT and of 5-H.IAA in  the bra in . The concentration of 5-HT 
was restored to normal when the corn d ie t  was supplemented with tryptophan 
fo r  17 days. However, when n ic o t in ic  acid was added to the d ie t  during 
a 7 day-period, the brain levels of 5-HT and 5-HIAA were not changed. On the  
other hand, when a synthetic  d ie t  d e f ic ie n t  in tryptophan was fed to rats  
(C u lley , et' a l . ,  1953) the concentrations of plasma tryptophan and of brain  
5-HT were lower by the fourth  day on the d ie t ,  and these changes were then 
s ta b i l is e d  fo r  the fo llow ing 24 days of observation.
I t  has been shown (Chapter 3) th a t  the tre b le -trea tm en t with n ic o t in ic  
a c id , ’ in su lin  and tryptophan in rats  changed more e f fe c t iv e ly  the concentra­
tions o f  tryptophan, 5-HT and 5-HIAA in d i f fe r e n t  parts o f the b ra in .
The present studies were designed to investiga te  the sequential e f fe c t  of 
th is  treatment on the changes in the tryptophan and i t s  m etabolites.  
Furthermore, since tryptophan-hydroxylase is a r a te - l im i t in g  enzyme in the 
synthesis of 5-HT, i t  was of in te re s t  to study the e f fe c t  o f the t r e b le ­
treatment on i t s  a c t iv i t y .
MATERIALS AND METHODS
Two groups o f adult female Wistar albino ra ts  were given n ic o t in ic  
acid, tryptophan and in s u l in ,  as described in the previous chapter. The
animals were then k i l l e d  at weekly in te rv a ls  and blood and brain removed, 
as described previously.
Tryptophan, 5-HT, 5-HIAA in d i f fe r e n t  parts of the brain and the  
plasma concentration of NEFA were determined as before. The soluble  
tryptophan-hydroxylase a c t iv i t y  was assayed, as described by Gal and 
Patterson (1973), with the m odification described by Green and Curzon (1970),  
fo r  the estimation o f the 5-HT formed in the incubation medium. The 
measurement of the tryptophan hydroxylase a c t iv i t y  was carr ied  out 
immediately on the day th a t  the animals were k i l l e d .  Five matched pairs  
of animals were k i l l e d  a t each time in te rv a l .  The soluble prote in  con- . 
centration  was determined using a m odification of the method described 
by Lowry, et a l . , (1951).
RESULTS
Table 4.1 shows th a t  the weight of the forebra in  was not changed by 
the tre b le -tre a tm e n t.  However, there was a suggestion fo r  an increase in 
weight of the brainstem and cerebellum by the fourth  week and a t  the f i f t h  
week the d iffe rence  was s ig n if ic a n t .
The concentration of to ta l  tryptophan in the plasma (Table 4 .2 )  of  
the experimental animals was lower than in the controls by week 4 but the 
d iffe rence  was s ig n i f ic a n t  ( P<0.05) only on week 5. The concentration of  
f re e  tryptophan, on the other hand, was lower on the treated  animals from 
week 1 and 'S ig n if ic a n t  at weeks 4 and 5.
The concentrations of tryptophan in the forebra in  and cerebellum  
were not changed s ig n i f ic a n t ly  by the treatment, but the concentrations  
in the brainstem was increased s ig n i f ic a n t ly  from week 3 onwards.
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In the trea ted  animals the concentration o f 5-HT in the fo rebra in  was 
lower from week 3 but the d iffe rence  was s t a t i s t i c a l l y  s ig n if ic a n t  only  
at week 5. In the cerebellum the 5-HT concentration in the treated  animals 
was s ig n i f ic a n t ly  lower ( P<0.05) from week 2.
The level of 5-HIAA in the forebra in  was s ig n i f ic a n t ly  lower a f te r  
5 weeks treatm ent, whereas in the cerebellum i t  was s ig n i f ic a n t ly  lower 
(P<0.05) a t  weeks 4 and 5. The level of 5-HIAA was unchanged in the  
brainstem.
The percentage change in the concentration of tryptophan, 5-HT and 
5-HIAA in each of the three parts of the brain are shown d iagram atica lly  
in F ig . 4. 1 .
The concentration of plasma NEFA was s ig n i f ic a n t ly  lower ( P<0.01)  
a f te r  week 1 onwards.
The a c t iv i t y  of tryptophan-hydroxylase was s ig n i f ic a n t ly  lower 
( P<0.05) in the brainstem and cerebellum a f te r  3 weeks treatment ( P<0.05)  
and in the cerebellum the d iffe rence  was greater (PcO.Ol) at week 5.
The a c t iv i t y  of the enzymes in the fo reb ra in ,  however, was not changed 
throughout the experiment. In add it ion , i t s  a c t iv i t y  in the forebra in  
and cerebellum increased with age.
DISCUSSION
The concentration o f plasma f re e  tryptophan was lower a f te r  4 weeks 
and th a t  o f to ta l  tryptophan a f te r  5 weeks of t re b le -trea tm en t with  
n ic o t in ic  acid , in su lin  and tryptophan. On th is  treatment the concentra­
t io n  of tryptophan in the brainstem was s ig n i f ic a n t ly  increased from 
3 weeks onwards.
However, the level of 5-HT in the brainstem remained p r a c t ic a l ly  
unchanged over the e n t ire  period of 5 weeks. This was in contrast to the 
changes in the cerebellum where a small increase in the concentration of  
tryptophan a f te r  3 weeks treatment was accompanied by a decrease in the 
concentration o f 5-HT. This may suggest th a t  tryptophan has an in h ib ito ry  
e f fe c t  on the synthesis of 5-HT by reducing the a c t iv i t y  of tryptophan- 
hydroxylase which was found to decrease in the brainstem and cerebellum  
a f te r  3 weeks treatm ent. This is  in agreement with the in v itro .  
observations ( F i g . 2. 7 ,  p . 69 ) ,  th a t  increasing the concentrations o f  
L-tryptophan (0 .1  to 4.0:ym/ml) in the incubation medium at a f ix e d  level  
of DMPH^  (0.46ym/ml) reduced the a c t iv i t y  of tryptophan-hydroxylase.
This suggests th a t ,  in v ivo , a high concentration o f tryptophan in the  
brainstem would exceed th a t  required fo r  the optimal a c t iv i t y  of t ry p to -  . 
phan-hydroxylase and hence th a t  i t  would act as a feedback in h ib i to r  fo r  
5-H.T synthesis.
The fa c t  th a t  increasing the concentrations o f  5-HT to the incuba­
t io n  mixture containing the enzyme lowered the fluorescence, compared to  
the standard curve of 5-HT incubated without enzyme ( F ig . 2.9, p.7 1 ) ,  
suggests th a t  there was product feedback in h ib i t io n .  This appears to 
be in agreement with GlowiiTski's (1972) f ind ing  th a t ,  in v i t r o , the  
regulatory  process of the hydroxylation step in 5-HT synthesis is  
contro lled  by a negative feedback acting by end-product in h ib i t io n ,  
whereas, in v ivo , i t  has been suggested (Hamon & Glowinski, 1975) to  
be due to the in te rru p tio n  of the flow  o f  nerve impulses on the serotonergic  
neurones. I f  th is  were so, i t  could be antic ipated  th a t  when the nerve 
impulse flow was disturbed by the accumulation of the 5-HT formed, the  
transport o f the enzyme from the neuronal c e l l  body to the nerve ending 
might also be in terrupted  and subsequently in h ib i t  the supply of the
tryptophan hydroxylase on the functional s i t e .  In th is  connection i t  
might be of in te re s t  to measure the flow of nerve impulses or serotonin  
turnover in the synapses in response to the tre b le -trea tm en t.
Moreover, i t  is possible th a t  the action of n ic o t in ic  acid and 
insu lin  in reducing cAMP (G uidotti  & Costa, 1973) by in h ib it io n  of 
adenyl-cyclase may have influenced the synthesis of enzyme-p.rotein, 
due to in te rfe rence  with the formation of messenger RNA (Mandell & Knapp,
• 1978) and consequently reducing the amount of tryptophan-hydroxylase in  
the serotonergic neurones.
Tryptophan-hydroxylase is inducible  by corticostero ids  (Azmitia & 
McEwen, 1969). Reduced levels  of NEFA, resu lt in g  from the action of 
n ic o t in ic  acid and in s u l in ,  may suppress the formation of such hormones 
and hence in h ib i t  the a c t iv i t y  of tryptophan-hydroxylase.
Ikeda, e t  a l . ,  (1966) indicated that metabolic in te rru p tio n  due to  
competition between end-product and cofactor fo r  the ac t ive -s .ite  of the 
enzyme might be responsible fo r  the changes in a c t iv i t y  of such an enzyme. 
The concentrations of cofactor influences the v e lo c ity  of enzyme action  
( F ig .2 .8  9 p . 70) fo r  when concentrations of DMPH^  were over 0.46ym/m (a t  
a constant concentration o f  tryptophan of lym/ml) the ra te  o f tryptophan- 
hydroxylase was reduced.
Thus, the a v a i l a b i l i t y  of tryptophan and the level of 5-HT formed 
as well as the concentrations of cofactor in the brain contribute  to the 
a c t iv i t y  of tryptophan-hydroxylase.
CHAPTER 5
FACTORS AFFECTING TRYPTOPHAN 
UPTAKE IN BRAIN REGIONS.
INTRODUCTION
I t  has been suggested tha t  a number of factors  a f fe c t  the uptake 
of tryptophan into  the brain and .the subsequent synthesis of serotonin. 
These fac tors  have been reviewed in d e ta i l  in Chapter 1. They include  
increasing the carbohydrate content o f the d ie t  (Fernstrom & Wurtman, 
1971a, c . ) ,  psychotropic drugs ( Graham-Smith, 1971) or changes in the  
ra te  of synthesis and catabolism of 5-HT (Curzon & Knott, 1974).
However, there is  s t i l l  considerable controversy over the r e la t iv e  
importance of each of these fa c to rs .  This chapter presents studies in 
which corre la t ion s  have been attempted between some of the various  
factors  in the same animals.
MATERIALS AND METHODS
Ten groups of adult female Wistar albino rats  were treated  and 
plasma as well as brains were analysed, as described in Chapter 3. 
Appropriate corre la t ion s  were calculated between concentrations of  
the various constituents in the brain regions and in the plasma, 
using an SPSS System Programme on a Surrey Prime computer.
RESULTS
1. The corre la t ions between the regional brain and plasma concentra- . 
t ions of tryptophan.
Figure 5.1 shows th a t  there was no co rre la t io n  between the  
plasma concentration of f re e  tryptophan and the concentration of t ry p to -  . 
phan in the whole or in  d i f f e r e n t  parts of the b ra in . However, the 
concentration of tryptophan in the brain stem and in the cerebellum was 
corre la ted  with the to ta l  tryptophan concentration in the plasma ( P<0.0 2 ) .
LO
o
Ln i lt> 
cm o  Ico • II
♦ o  •O CO QJ
I V  Q.II n o  
Ou I—S- *  >- CO
COr^ .
C\J
oI
II 
%.
cn
co
o
I CM
ii ii 
S- > -
CD
OI
II
S-
u
LO Xo
II • on
;> I— !---
-----CM
00 o + II•
COOOl QJ• • CL
O  Y I— o
II CL II CO
*
s- * > -
“*r*«------ 1----x  x«sj- I—
ii •
p> ' — -CD cm 
 CMO O + II
C O O M U  
• o .
O  V CM O
*3*
II
7>
CO
CM LO 
•  •
O I— 
II II* 
S- > -
*3*II
;>
CO
'CM Oo  +
•A  V V
CO
CMo
o
II
S-
LO
CT>o
9
II
S-
o 
on 
CM 
._* CO<Z> 
I ' ­
ll II.
s->-
rd
oj 
o
I V
QJ4->10
c
• r—
rds-0Q
rdS-JD
QJ
S-
o
0J
JO
QJs-
QJo
o
CO
o
CM
A  V o
CO
“I—o
LO
o Ao
CO
V o
CM
- Ao o
CM
s z CO
CL c
o o
p •r-
CL P
o as
CM S- s-
P p
E
rd 0J
£ o
CO e
rd o
r—
CL
o
0J
LO r— s z
r— as
p
p
o XI
-p c  ■
O
rd
P . e
as
0J s z
cu CL
s- o
O  P p
CL
cp >>
O E
P
O
•r* rd
P £
as to
• cc rd
CO
CL
o
—
f—
- 1— rd
E p
■ ■— o
on
-O CL
p  •
CM '---- o
'
c
p
as <u
s z QJ
C l s-
O
P
p
CL p
r?-
o
JLO -P o
r— •1—
rd p
£ rd
to S-
asi— E
CL o
,— , — . .
■ rd XI e
P -'•r—
-o  o rd
r— |— r— S_\ rd JO 
P
O CU 
P  JO 
p
LO A
^—p
' cm rd O
to 
CU P  
QJ E„—^ E rd
r —
£
P  CL
E QJ
cn QJ JO
O  P- QJ P
-  » 3=
CM P  E
- C QJ * r -
rd JO
JO c
CL to rd
O C JO
P O CL
CL •i— o
■>> p  p
s- rd CL
LO P r“”• cu e
1— td E P
£ E
to O P
rd 1— o  o
CL
0J .
CU
O  S-
LO
• Li_ QJ
“ r— e
\ Z5cn•i—
Ll_
(6/6ri) ueifdoid/Q} ULBjg
«%!■oo
o
II
S-
cO
00CO
oI
II
E
*3-
CT>
o
I
II ,
s-
CM
oI
II
e
A V A V A  V
o
CM
uo
-  LO
o o o O O o o O O O O
• • • • • • • •- • • • •
■ CO CM ^  LO CO CM CM r -  • LO CM •“ *
LO
CO CO
II II X
p> CO • i—
------CM CO *—'CM LO r^ -
r^- o . o • 0 0
• X  o CM • I o r^.
O O  1 LO O i o
• r— II CO i— ii •
O  V I a  v .  . . o
1 CO cu I LO CU 1
O- CL a . CL
II II o ii II o It
* 1— * r—E * >- CO e  * >- CO E
cu
O ■
CO
e
JOcu
E
o
Ll_
o
CM
LO
-tA V
o
"51-
o
CO
o
CM
o
LO
o o
CO
-A
o
CM
T-\ V
o o 
•  •
CM I—
o
CM
q-
O
■ Z3 ■ ■■ 
CO
CU
j c  ■ 
+->
o
+ j
EfO
S Z  - 
CLo
4->
CL
4-3
CO
E
to to 
CO "O
I—  -I—Q. O 
CO
CO O  
4-> C  
O  • « -  
4-> E  
c0q-
O  r— 
CO 
O  E  
- r -  4-3 
4-3 3  
CO CU C£ c
LO
O
q-o
to
cu
s z
4-3
O
4-3
E
CO
S Z
CL
o
4-3
Q -
4-3
CO
E  to 
to XJ
CO t — 
r—  O
CL CO
CU o  
CU E  
E  -i—
q- e
c0
q-
O  r—
cO o  e
•r -  4-3 
4-3 3  
CO CU 
C Z  E
(6/6rt) uei]doq.d/Cuq. ULBjg F
ig
ur
e 
5.
2 
C
or
re
la
tio
ns
 
be
tw
ee
n 
th
e 
ra
tio
 
of 
fre
e 
(a
) 
or 
to
ta
l 
(b
) 
pl
as
m
a 
tr
yp
to
ph
an
 
to 
th
e 
sum
 
of 
th
e 
ot
he
r 
n
eu
tr
 
am
in
o 
ac
id
s 
an
d 
th
e 
co
nc
en
tr
at
io
ns
 
of 
tr
yp
to
ph
an
 
in 
th
e 
pa
rt
s 
of 
th
e 
br
ai
n
00
(a)
800
600 -
400
r  = 0.042
A  A
▲
A
A
A A
/*"
C
fO
COfO
Q . 
E ■
CO
T3
o03
Oc
03
CDc
•r~4->O)
Q .
E .O01c
rdJC
CLO4->
Q .
■fc4->
H-O
800 -
600
400 -
(b)
1 . 0 .  1.5
Free plasma tryptophan (yg/ml)
2.0
(v = 47)
Y = 278 + 21X
T
10 15
Total plasma tryptophan (yg/ml)
20
1,000 
; 800 ■ 
600 ' 
400
(c)
A A
r  = -0.361 (v 
+ P < 0.05  
Y = 845 -  46X
= 30)
187 10 15
Ratio o f f r e e / t o t a l ,  plasma tryptophan {%).
Figure 5.3 Correlations between free  (a) to ta l  (b) or r a t io  o f f re e  t o - t o t a l  (c )  
plasma tryptophan and the sum o f  the neutral amino acids in  the plasma
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The slope o f the regression l in e  between the concentration o f tryptophan 
in the plasma and in the brain stem (slope = 27) was higher than th a t  in 
the cerebellum (slope f  8 ) .  The r a t io  of f re e  to to ta l.p lasm a tryptophan 
was negative ly  corre la ted  _(P<0.05) with the average concentration of 
tryptophan in the whole brain but not with the concentration of tryptophan 
in the d i f fe re n t  parts of the b ra in . Neither the concentration of f re e ,  
t o t a l ,  nor the r a t io  o f  f re e  to to ta l  plasma tryptophan was corre la ted  
with the concentration of tryptophan in the fo reb ra in .  Figure 5.2 shows 
tha t there was a s ig n if ic a n t  negative corre la t ion  (P<0.02) between the  
concentration of tryptophan in the whole b ra in , brainstem and cerebellum  
but not in the fo re b ra in ,  and the r a t io  of f re e  tryptophan to the sum of 
the neutral amino acids in the plasma. The concentration of tryptophan 
in any of the the parts of the brain did not c o rre la te  with the r a t io  
of to ta l  tryptophan to the sum of neutral amino acids in the plasma.
Figure 5.3 shows th a t  the sum of these amino acids was p o s it iv e ly  
correlated ( P<0.05) with the to ta l  concentration of tryptophan in the  
plasma ( P<0.05) and negative ly  corre lated  ( P<0.05) with the r a t io  of f re e  
to to ta l  plasma tryptophan but not with the f re e  plasma tryptophan.
The concentration of non -es te r if ied  f a t t y  acids in the plasma was 
s ig n i f ic a n t ly  re la te d  (P<0.~02) to the plasma concentration o f f re e  
tryptophan but not to the to ta l  tryptophan or to the r a t io  of f re e  to 
to ta l  tryptophan in the plasma (F ig u re 5.4).
2. The co rre la t io n  between the regional concentrations of tryptophan
and of 5-HT in the brain
Figure 5.5 shows th a t  there was. no .co rre la tion  between the concentra- . 
t io n  o f  tryptophan and th a t  of 5-H.T in the cerebellum and in the brain  
stem. On the other hand, there was a co rre la t io n  (P<0.05) between the  
concentration of tryptophan and th a t  of 5-HT in the fo rebra in  and in the  
whole b ra in . . - .
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3. The co rre la t io n  between the regional concentrations of 5-HT
and of 5-HIAA in the brain
Figure 5.6 shows th a t  there was no co rre la t io n  between the concentra­
t ion  of 5-HT and of the 5-HIAA in the cerebellum and brainstem, whereas 
there was a p o s it iv e  co rre la t io n  between these concentrations in the 
forebra in  (P<0.01) and in the whole brain (P<0.02)
DISCUSSION
The present study demonstrated th a t  the concentration of tryptophan 
in the brainstem and in the cerebellum was re la ted  to the concentration  
of t o t a l ,  ra ther  than to the f re e ,  plasma tryptophan. On the other  
hand, the concentration of tryptophan in the forebra in  did not seem to  
be regulated by the plasma levels  of tryptophan and to remain unchanged 
in sp ite  of changes in the plasma concentration. Thus, the resu lts  may 
support the contention (Fernstrom, e t  a l . ,  1976) th a t  the plasma con­
centration  of t o t a l ,  ra ther  than f re e ,  tryptophan is the re levant index 
fo r  predicting  the tryptophan levels  in the brainstem and in the • 
cerebellum.
Other workers (Biggio, e t  a l . ,  1974, Perez-Cruet, e t  al.. , 1974, 
Yuwiler, e t  a l . ,  1977) have suggested tha t both competition with other  
neutral amino acids and binding to plasma albumin might be important 
in determining the re la t io n  between plasma neutral amino acids and 
brain tryptophan concentrations. I f  th is  were so then the r a t io  of  
f re e  plasma tryptophan to the sum of the other neutral amino acids 
would be expected to co rre la te  with the brain tryptophan concentration.
The present resu lts  are in agreement with th is  suggestion fo r  the  
co rre la t io n  between the r a t io  of f re e  serum tryptophan to the sum of
i t s  competitors fo r  uptake and. the concentrations of tryptophan in the  
brainstem and in the cerebellum was b e tte r  than th a t  obtained when the  
r a t io  o f to ta l  plasma tryptophan was used.
A possible mathematical explanation fo r  these re la tionsh ips  may be 
th a t  the f re e  plasma tryptophan changes w ith in  a small range, while the 
to ta l  plasma was about ten times la rg e r .  The fre e  plasma tryptophan 
was, th ere fo re , r e la t i v e ly  constant compared with the changes of the 
to ta l  plasma tryptophan. The resu lts  showed also tha t  the sum of 
neutral amino acids was re la ted  to the to ta l  plasma tryptophan and thus 
was negatively  corre la ted  with the r a t io  of the f re e  to to ta l  plasma 
concentration of tryptophan. I t  was also found that the r a t io  o f f re e  
tryptophan to the sum of the neutral amino acids was negative ly  corre la ted  
with the to ta l  plasma tryptophan and hence with the brain tryptophan.
Thus, the tryptophan concentration in the brainstem and in the ■* 
cerebellum depends on the to ta l  plasma tryptophan and, 'a l te rn a t iv e ly ,  
upon the r a t io  o f f re e  plasma tryptophan to other neutral amino acids 
competing fo r  transport from blood to bra in . Furthermore, the resu lts  
showed th a t  the concentrations of 5-HT in the cerebellum and brainstem  
seemed to be r e la t i v e ly  constant (F ig . 5.5 ) in sp ite  of the f ind ing  
th a t  the uptake o f tryptophan in these regions was more e f fe c t iv e  than in  
the other part of the b ra in . On the other hand, the fo rebra in  and 
hence the whole brain showed a dependence of 5-HT formation on t ry p to ­
phan concentration. Thus, the re la tionsh ips  between the high a f f i n i t y  
of tryptophan uptake, the tryptophan-hydroxylase a c t i v i t y  and, possib ly ,  
the overa ll  conversion.of tryptophan to 5-HT appeared to vary according 
to the sp e c if ic  brain regions.
CHAPTER 6
EFFECTS OF NICOTINIC ACID, INSULIN AND 
TRYPTOPHAN ON THE PHYSICAL ACTIVITY AND 
INTERFEMALE-BEHAVIOUR OF ADULT RATS
INTRODUCTION
A number of animal studies have attempted to e luc idate  the function  
of brain 5-HT in mood and behaviour by using sp e c if ic  pharmacological 
agents. Amphetamine is known to produce h yp erac t iv ity  during the ear ly  
stages o f ingestion and th is  is associated with increased a v a i l a b i l i t y  
of 5-HT in the brain (Glowinski, e t ' a l . ,  1956). Other drugs, on the  
other hand, th a t  deplete the brain level o f 5-HT may induce a s ta te  of  
•depression and lethargy (Hanin, 1978). In add ition , Graham-Smith (1971) 
indicated th a t  in ra ts  pretreated with an MAO in h ib i to r ,  followed by a 
tryptophan load (50 mg/kg), a r is e  in the brain level of 5-H.T was 
associated with the production of h yp erac t iv ity  and hyperpyrexia. Thus, 
i t  seems possible th a t  n u t r i t io n a l  fac to rs  which a l te r  5-H.T metabolism 
may a f fe c t  a c t iv i t y  and behavioural-p.attern.
I t  has also been shown th a t  pharmacological manipulations of 5-HT ' 
metabolism can change feeding behaviour (B lunde ll,  1977;' Hoebel, 1977). 
A depletion of 5-HT synthesis in r a t  brain a f te r  treatment .with p-CPA 
resu lts  in decreased food intake (McFarlain & Bloom, 1972).
The present study was undertaken to examine the e ffec ts  o f t r e a t ­
ment with n ic o t in ic  acid , insu lin  and tryptophan on the physical 
a c t iv i t y  and behavioural responses in the r a t .
MATERIAL AND METHODS
Two groups of f iv e  ra ts  were tre a te d , as described in Chapter 4.
The ra ts  were housed separately and the cumulative food intake  
monitored weekly. The physical a c t iv i t y  was scored, as described 
before (Chapter 2 ) ,  s ta r t in g  24 hours a f te r  the i n i t i a l  adm inistration
and measured at weekly in te rv a ls  fo r  f iv e  weeks.
The behavioural observations were also made weekly using an adapted 
method of Grant and Mackintosh (1963). (see Chapter 2 ) .
The contr ibution  o f a c t iv i t ie s  in each category to X2 was examined 
to f in d  out whether the occurrence of any category was s ig n i f ic a n t ly  
alte red  by the treatm ent. The overa ll  value o f X2 fo r  each group was a 
measure of the to ta l  behavioural e f fe c t .
RESULTS
Table 6.1 shows th a t  the treb le -trea tm ent had no s ig n if ic a n t  e f fe c t  
on the cumulative food intake of the fa ts .
Figure 6.1 shows the a c t iv i t y  scores o f the control animals were 
r e la t iv e ly  consistent ( r  = 0 .02; y = 1300) throughout the experiment, 
whereas the experimental animals showed lower mean scores throughout, 
although the d ifference did not become s ig n if ic a n t  u n t i l  a f te r  week 2. 
The greatest d ifferences were found at weeks 3 and 4.
Table 6 .2  shows the frequency of indiv idual a c t iv i t ie s  shown a f te r  
one week of t re b le -trea tm en t.  The to ta l  number of a c t iv i t i e s  was 
s ig n i f ic a n t ly  higher (X2 = 27.29, PcO.OOl) in the experimental group.
The categories of the behaviour most affected were the non-social 
a c t iv i t i e s  ( P<0.01) and the defensive aggression (P<0.01) in the 
experimental ra ts .
The to ta l  number of the a c t iv i t ie s  observed in week 2 (Table 6 .3 )  
was Jess in both groups (154 and 194 vs. 212 and 287) than th a t  >  
a f te r  treatment in week 1 and was p a r t ic u la r ly  so in a c t iv i t i e s
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Table 6 . 2 .  E ffects  of the treb le -trea tm ent on the occurrence of ind iv idual
a c t iv i t i e s  and the contribution  to X2 by each category of the
a c t iv i t i e s  on Week 1.
(Values are to ta l  frequency of a c t iv i t i e s  fo r  f iv e  animals in 
each group).
A c t iv i ty
Observed frequency .
Control Experimental Contribution to X
Non-social behaviour 
explore  
leave
self-groom
Social behaviour 
atten tion  
approach 
investiga te  
nose
32
8
13
8
7
12
12
37
8
0
12
7
11
13
12.79**  (2)
0 .69 (3)
Sexual behaviour 
fo llow  
s n i f f
attempted mount 
mount
post-copulatory groom
Offensive aggression 
aggressive posture 
aggressive groom 
offensive sideways 
chase 
th rea t  
b ite  
attack  
v ic to ry  
t a i l  r a t t l in g
Defensive aggression 
f l i g h t  
kick  
evade 
re t re a t  
crouch 
submission 
defensive sideways
35
52
23
17
7
37
82
33
3
6
13
20
25
1.87 (2)
1.69 (2)
10 .25**  (1)
TOTAL 237 297 2 7 .2 9 ** * (1 4 )
S t a t is t ic a l  s ign ificance: **P<:0.01 ,***Fk0 .001,degree o f freedom,
as indicated in brackets.
Table 6 .3 .  E ffects  o f the tre b le -trea tm en t on the occurrence o f ind iv idual
a c t iv i t i e s  and the contr ibution  to X2 by each category o f the
a c t iv i t i e s  on Week 2.
(Values are to ta l  frequency o f a c t iv i t ie s  fo r  f i v e  animals in 
each- group).
A c t iv i ty
Observed frequency 
Control Experimental Contribution to X2
Non-social behaviour 
explore  
leave
self-groom
Social behaviour 
atten tion  
approach 
investigate  
nose
25
11
28
16
0.30 (1)
1.76 (3)
Sexual behaviour 
fo llow  
s n i f f
attempted mount 
mount
post-copulatory groom
Offensive aggression 
aggressive posture 
aggressive groom 
offensive  sideways 
chase 
. th rea t  
b ite  
attack  
v ic to ry  
t a i l  r a t t l in g
Defensive aggression 
f l i g h t  
kick  
evade 
re t re a t  
crouch 
submission 
defensive sideways
16
31
7
4
12
1
18
1
1
0
18
34
9
4
11
3
19
0
5
3
38
0
1
1
1
1.11 (3)
6.95 (5)
10.09 (4)
TOTAL 154 194 2 0 .21 ** (19 )
S ta t is t ic a l  s ign ificance: *P<0.05, **P<0.01 degree of freedom,
as indicated in brackets.
Table 6 .4 .  E ffects  of the tre b le -trea tm en t on the occurrence o f ind iv idual
a c t iv i t i e s  and the  contr ibution  to X2 by each category o f the
a c t iv i t i e s  on Week 3 .
(Values are to ta l  frequency o f a c t iv i t ie s  fo r  f iv e  animals in 
each group).
A c t iv i ty
Observed frequency 
Control Experimental Contribution to X2
Non-social behaviour 
explore  
leave
self-groom
Social behaviour 
atten tio n  
approach 
investiga te  
nose
48
8
15
2
14
12
2
56
0
20
2
7
14
2
9 .17* (2)
2.05 (3)
Sexual behaviour
fo llow 29 32
s n i f f 36 46
attempted mount 24 18
mount 2 0
post-copulatory groom - -
^nsive aggression
aggressive posture 15 14
aggressive groom -
offensive  sideways - -
chase 29 23
• th rea t - -
b i te - -
attack - -
v ic to ry - -
t a i l  r a t t l in g - - ■
insive aggression
f l i g h t 0 6
kick 26 67
evade - -
r e t re a t 0 1
crouch -
submission 0 2
defensive sideways - -
4.09 (3)
0.12  ( 1)
13 .01 **  (3)
TOTAL 262 310 2 8 .4 4 ** * (1 4 )
S t a t is t ic a l  s ign ificance: *P<0.05, **P<0.01, ?**P<0.001, degree of freedom,
as indicated in brackets.
Table 6 .5 ,  E ffects  o f the tre b le -trea tm en t on the occurrence o f ind iv idual
a c t iv i t i e s  and the contr ibu tion  to X2 by each category of the
a c t iv i t i e s  on Week 4.
(Values are to ta l  frequency of a c t iv i t ie s  fo r  f iv e  animals, in 
each-group).
A c t iv i ty
Observed frequency 
Control Experimental Contribution to X
Non-social behaviour 
explore  
leave
self-groom
Social behaviour 
a tten tion  
approach 
investiga te  
nose
4
28
11
24
16
4
26
0.01 ( 1)
12. 11**  (2)
Sexual behaviour 
fo llow  
s n i f f
attempted mount 
mount
post-copulatory groom
Offensive aggression 
aggressive posture 
aggressive groom 
offensive  sideways 
chase 
th rea t  
b ite  
attack  
v ic to ry  
t a i l  r a t t l in g
Defensive aggression 
f l i g h t  
kick  
evade 
r e t re a t  
crouch 
submission 
defensive sideways
28:
48
11
7
11
19
2
20
23
58
7
6
0
27
59
20
3
13
32
1
16
24
74
23
10
1
4.28 (3)
3.41 . (3 )
6.28 (4)
TOTAL 323 • 347 2 6 .0 9 * * ( 17)
S t a t is t ic a l  s ign ificance: \  **P<0.01 degree of freedom,
as indicated in brackets.
Table 6 .6 .  Effects  of the tre b le -trea tm en t on the occurrence o f ind iv idual
a c t iv i t i e s  and the contribution  to X2 by each category of the
a c t iv i t i e s  op Weeks.
(Values are to ta l  frequency of a c t iv i t ie s  fo r  f iv e  animals in  
each group).
A c t iv i ty
Observed frequency 
Control Experimental Contribution to X-
Non-social behaviour
explore - -
leave - -
self-groom 12 28
Social behaviour
atten tion 6 14
approach 23 8
investiga te 21 17
nose 3 3
Sexual behaviour
fo llow 33 23
s n i f f 63 60
attempted mount 18 15
mount 15 2
post-copulatory groom 0 3
Offensive aggression
aggressive posture 21 17
aggressive groom - -
offensive sideways 12 13
chase 22 22
th re a t - _
b ite 0 3
attack 5 11
v ic to ry - -
t a i l  r a t t l in g - -
Defensive aggression
f 1ight 20 33
kick 33 76
evade - -
re t re a t 19 28
crouch 16 14
submission 8 3
defensive sideways 5 12
0.34 ' ( 1 )
9 .74*  (3)
12.31* (4 )
5.44 (4 )
12.05* (5 )
TOTAL 355 405 37 .8 8 ** (2 0 )
S ta t is t ic a l  s ign ificance : *P<0.05, **P<0.01 degree of freedom,
as indicated in brackets.
Ta
bl
e 
6.
7.
 
Ef
fe
ct
s 
of 
th
e 
tr
eb
le
-t
re
at
m
en
t 
on 
th
e 
oc
cu
rr
en
ce
 
of 
co
nt
ri
bu
ti
on
 
to 
X2 
fo
r 
ea
ch
 
ca
te
go
ry
 
of
 
be
ha
vi
ou
r 
ob
se
rv
ed
 
se
q
u
en
ti
al
ly
.
— I ^
4-5
ZZ 4c
CU 4: 4cE 0 0 CM CO LO LO LO
•r - CM O LO LO O
S- ■ ■ r— r— «d- 'd '
LO CU -— -■
C l LO
-X  X •
CU U J CO
cu CM
3  ■—o II
u CM CO CD o r— LO
4-5 r— LO CM LO o LO CM
zz r— r — CO Xo
CJ>
4-5
c 4C 4c
cu 4c 4c
E o LO CD r— CM I X
•I— CO «d- O LO CO r x
S- r— r— CO v _^
* d  cu CD
Q . O
.X  X «
CU U J X
cu CM
3  *—o II
S- CM r— < d CM CO
4-5 CO LO CD LO CD CM cm
c - CO. X
o
c_>
4-5
SZ 4c 4c
cu 4: 4cE LO LO LO t x LO O ✓— s.
•r— i x CM CD CO r x i— «d*
S- CO v___ *
c o  cu O
Q . o
X  X *
(U U J CM
cu CM
3 :  r—
o II
s - ■—- o I-— 'd ' LO CM <
4-5 i x CO CD ■d- CM LO CM
sz CM Xo
C_)
4-5
c
cu 4c 4c
E «d- <d- LO o f— *d* ,*■—^
•i— r— LO CO «d- CD
S- r— -—
CM <u r —
CL «d-
-X  X
CU U J r—
cu r—
1 2  f—o II
S- LO «d- 0 0 o o o o «d-
4-5 CO f— LO CO r— LO CM
ZZ r — X
o
o
4-5
SC
cu 4c 4c
E LO CO CM CM LO r x —I•r— CO LO CM *d- CD
S - r— CM •»__-
r— CU CM
CL LO
- X  X •
CU UJ CO
cu
3  r— IIo
S- CO CD o r— «d- r x CM
4-5 t o CO r— r— CM CO X
sz r— CMo
c_>
S-. £ -
z s =3 • ZZ SZ
s - o O o o
Z2 •r* •r - •r - •r—
o > . > CO CO
•r~ rd rd CO CO
r—  > JC JT CU CU _ i
> > rd rd cu CU CU S- CU S- C
S- •f— SZ JO JO >  CD >  CD 1—o o  cu •r— CD •r— CD o
CD o s z r— r— CO rd CO rd h -
cu to rd rd c ZZ
4-5 1 •i— • 3 cu a>
rd zz o X n - 4 -
o o o CU <+- cu
z o o o o o Q
i 1— CM CO LO
S-o
CD Q) 
4-5 
rd O
SZu
rd
(1)
. S-oM-
co
cu
4-5
CJfO
i .cu
SZ3 
E 3c
rd
4-5O4-5
CU
SZ
4->
CUs-
rd
COcu
13
rd S
ta
ti
st
ic
al
 
si
gn
if
ic
an
ce
 
=*
P<
0.
05
; 
**
P
<0
.0
1.
concerned with the social and sexual in te re s t .  By the second week the  
differences in non-s.ocial behaviour had disappeared but defensive  
performance with increased frequency o f d e fen d in g -ac tiv ity  was again 
s ig n i f ic a n t ly  d i f f e r e n t .  -
The a c t iv i t y  at week 3 was very s im ila r  to th a t  of week 1.
Differences in non-s.ocial ( P<0.05) and defensive behaviour (P<0.01) 
were again s ig n if ic a n t  and the a c t iv i t i e s  most affected by the  
treatment (Table 6 .4 ) .
Table 6 .5  shows the to ta l  number of a c t iv i t i e s  was s ig n i f ic a n t ly  
changed (X2 = 26.09; P<0.01) at week 4. The experimental animals
showed a low social a tten tio n  ( P<0.01) to th e i r  partners.
The to ta l  number of a c t iv i t i e s  in animals with treb le -trea tm en t  
at week 5 was again s ig n i f ic a n t ly  higher (X 2 = 37.88; P<0.01). The
defensive performance was s ig n i f ic a n t ly  increased (P<0.05) and the  
social as well as sexual in te re s t  was s ig n i f ic a n t ly  reduced (P<0.05). (Table
The overa ll  contribution  to X2 of each category of behaviour 
observed seq uentia lly  are shown in Table 6 .7 .  The only category in  
which there was a consis ten tly  higher value in the experimental 
animals was in defensive aggression.
DISCUSSION
The tre b le -trea tm en t s l ig h t ly  but in s ig n if ic a n t ly  reduced the  
cumulative food in take . Other studies have shown th a t  tryptophan 
(50mg/kg i . p . )  (Latham & B lundell, 1979) or 5-HTP (50mg/kg i . p . )
(Singer, e t  a l . ,  1971) exerted a s ig n if ic a n t  in h ib ito ry  e f fe c t  on food
intake in ra ts .  Although our study did not provide d ire c t  evidence of  
a possible functional ro le  fo r  5-HT in the regulation  o f feeding-  
behaviour, i t  is  possible th a t  th is  does occur by a control o f s a t ia t io n  
in the hypothalamus (Hoebel, 1977).
The a c t i v i t y  scores were lower a f te r  the th ird  week of t r e b le -  . 
treatm ent. Moreover, the ra ts  showed an increase in defensive aggression 
and a lack o f social in te re s t  during subsequent weeks of treatm ent.
These observations could mean th a t  the experimental animals showed th a t  
a decrease in locomotor a c t iv i t y ,  accompanied by an increase in i r r i t a b l e  
behaviour which could have been associated with the depletion of 5-HT 
in certa in  parts of the bra in . This observation seemed to be in agree- . 
ment with th a t  of Graham-Smith (1971) who observed h yp e ra c t iv ity  in  ra ts  
given a dose of tryptophan fo llow ing an MAO in h ib i to r .  For in th a t  
study the increment a c t iv i t y  was associated with an accumulation o f  5-HT. 
However, Taylor (1976) has reported th a t  tryptophan-load alone (20mg/kg) 
decreased locomotor a c t iv i t y .  This could be due to a d ire c t  e f fe c t  of 
tryptophan i t s e l f ,  since reaction poten tia l  of c e l ls  was changed when 
tryptophan was applied m icro ion tophoretica lly  into  the brain (Wayner, 
e t  al.. ,  1975). Therefore, i t  would be of in te re s t  to f in d  which o f the  
n u tr i t io n a l  constituents administered d id , in f a c t ,  produce le thargy ,  
i r r i t a b i l i t y  and withdrawing behaviour, or whether i t  was an in te ra c t io n  
between them.
However, i t  is  not certa in  whether these e f fe c ts  were due so le ly  
to  the n u t r i t io n a l  treatment. Another fa c to r ,  such as 's t r e s s ' ,  which 
enhances aggression in rodents subjected to iso la t io n  (Baer, 1971), has 
also been regarded as a consequence of 'socia l depriva tion ' and is  said  
to re s u lt  in ' i r r i t a b i l i t y ' .  Brain and Benton (1979) indicated th a t  the
word 's tre s s ' is  used to re fe r  to an id e n t i f ia b le  physical or psychological 
fa c to r ,  which tends to deplete or impair the e f f i c ie n t  u t i l is a t io n  of an 
animal's energy reserves. Moreover, ' i s o la t io n ' ,  or other s tress fu l  
treatments, i . e .  in jections-, oral-d.osing or handling or a c t iv i t i e s  going 
on outside the animals' cages, may induce the production o f oestrogen 
or adrenocortical hormones in female rodents (Brain & Benton, 1979).
Changes in these hormones may contribute  to changes in the neural concentra 
t ions of biogenic amines and in th is  way a f fe c t  the functioning o f  the 
brain .
The present studies have shown th a t  the tre b le -trea tm en t reduced 
the concentration of 5-HT in the cerebeilum from week 2 onwards and at  
a la te r  time also reduce them in the fo rebra in . In the brain stem, 
however, the concentration of 5-HT was r e la t iv e ly  unchanged (see Chapter 4) 
These changes were accompanied by a decrease in locomotor a c t iv i t y  and 
an increase in defensive aggression of the animals a f te r  week 2 o f  the 
treatment. I t  seems possible th a t  the changes in the 5-HT concentration  
in the cerebellum could, in f a c t ,  account fo r  the changes in a c t iv i t y  
because the cerebellum is e s s e n t ia l ly  a motor part  o f the b ra in , making 
a special contribution  to the maintenance and coordination o f muscle 
action in movement. Moreover, the lim bic system of the fo rebra in  is  
also concerned with motivation and emotion (White, 1965). In add it ion ,  
as the concentration of 5-HT in the brain stem was r e la t i v e ly  unchanged, 
i t  may be th a t  s a t ie ty  and feeding control v ia  the hypothalamus remained 
p ra c t ic a ly  unaffected by the tre b le -trea tm en t.
Thus i t  seems possible th a t  n u t r i t io n a l  fa c to rs ,  by v i r tu e  o f  t h e i r  
e f fe c ts  on 5-H.T metabolism in certa in  regions, may be associated w ith  
modifications in the functioning of specia lised parts of the b ra in .
CHAPTER 7 
GENERAL DISCUSSION
The present studies have shown in t r ic a te  changes in plasma levels  of 
tryptophan and in the concentrations o f tryptophan, 5-HT and 5-HIAA in 
the d i f fe r e n t  parts o f the brain of ra ts  given d i f fe r e n t  treatments  
consisting of various combinations of "nicotin ic  acid, in su lin  and 
tryptophan. In the animals given a f u l l  combined treatm ent, the changes 
in biochemical compounds were accompanied by a lte ra t io n s  in the a c t iv i t y  
of tryptophan-hydroxylase in d i f fe r e n t  regions. Moreover, formation o f  
5-HT in d i f fe re n t  regions responded d i f f e r e n t ly  to i ts  tryptophan con­
cen tra t io n . The changes in concentrations of tryptophan corre la ted  well 
with the concentration of 5-HT in the forebra in  but not in the b ra in ­
stem and cerebellum. I t  has also been shown th a t  in the brain-stern 
the a f f i n i t y  fo r  the uptake of tryptophan was r e la t iv e ly  high, but the  
a c t iv i t y  of tryptophan-hydroxylase was reduced, and in th is  way l im ited  
the conversion of tryptophan to 5-HT. In the fo reb ra in ,  on the other  
hand, .the a f f i n i t y  fo r  uptake of tryptophan was r e la t iv e ly  low and the 
synthesis of 5-HT seemed to depend on the a c t iv i t y  of tryptophan- 
hydroxylase. These observations seem to support the contention V 
(Mandell & Knapp, 1977) tha t  the a c t iv i t y  of tryptophan-hydroxylase  
has a l im i t in g  e f fe c t  on 5-HT synthesis in areas where uptake of t ry p to ­
phan is high.
The d i f fe r e n t  treatments have been shown to a l t e r  the plasma con­
centrations o f certa in  neutral amino acids which compete with tryptophan  
fo r  the uptake into the bra in . Tyrosine, formed p a r t ly  by hydroxylation  
of phenylalanine, is a precursor of the catecholamines. I t  might be 
expected th a t  changes in the plasma concentrations of tyrosine and 
phenylalanine, due to the d i f fe r e n t  treatments, would lead to a l te ra t io n s  
of the concentrations of tyrosine and phenylalanine in the brain
and consequently to the changes in the levels  of dopamine and noradren­
a l in e  in d i f f e r e n t  parts  of the b ra in . These were not examined and i t  
is therefore  necessary to carry out a fu r th e r  study on the e ffe c ts  of  
the d i f fe r e n t  treatments on the concentrations of dopamine and 
noradrenaline which have an antagonistic in te rac tion  with the function  
of 5-HT in d i f fe r e n t  brain regions. This approach, accompanied by 
determinations o f tyrosine-hydroxylase in d i f fe r e n t  regions would make 
i t  possible to e luc idate  the mechanism by which some of the changes o f  
amino acids in d i f fe r e n t  parts of the brain were brought about.
Most studies have attempted to co rre la te  the concentrations of 
plasma constituents (tryptophan, neutral amino acid and NEFA) with the 
uptake of tryptophan in the whole bra in . Values fo r  the concentration  
of tryptophan in the whole brain are the re s u lt  of the contributions made 
by the d i f fe r e n t  parts of the brain and our studies showed th a t  the 
concentration of to ta l  plasma tryptophan and the r a t io  of f re e  plasma 
tryptophan to the sum of other neutral amino acids were associated  
with the concentrations of tryptophan concentrations in the brain stem 
and cerebellum, but not in the fo rebra in . Thus changes in tryptophan 
concentrations in the whole brain were due almost e n t i re ly  to those in 
these two parts .
The present investigations have also shown th a t  changes in con­
centrations of 5-H.IAA fo llow  a s im ila r  pattern to those of 5-HT 
concentrations in d i f fe r e n t  regions (see F ig .5 .5  . and Fig. 5 .6  . ) .
A decrease in the concentrations of 5-HT and 5-HIAA in the fo rebra in  
and cerebellum (Chapter 4) may have some physiological s ign if icance .
The function  of certa in  morphological structures o f these regions has 
been suggested to be associated with the concentration of 5-H.T in the  
regions. These include changes in physical a c t iv i t y  and behaviour.
A suggestion tha t  the e ffe c ts  o f the n u tr i t io n a l  factors  on the 
changes in processes of 5-HT turnover occurring in neuronal and synapto 
somal f ra c t io n s  could, possib ly, contribute fu r th e r  information to  
co rre la te  the changes in 5-HT concentrations by those factors  and 
functioning of p a r t ic u la r  parts of the brain*
Da Prada and Pletscher (1956) have provided evidence th a t  an 
in h ib it io n  o f  5-HT reuptake by receptor s ites  at the postsynapse 
occur a f te r  adm inistration of a compound s t ru c tu ra l ly  s im ila r  to 5-HT 
(F ig . 7 .1 ) ,  (LSD, chlorimipramine) and hence causes a s e lec t ive  and 
prolonged reduction in 5-HT and 5-HIAA level in the brain regions 
(Baumgarten, e t  a l . ,  1972).
R4
4
R
R5 CH,
S 3
a
(*)
Fig . 7 .1 .  Indolealkylated  tryptamine (Shulgin, 1976).
R (a lk y l )  can be substituted with H; OH or complex ring structures
(H a ig le r  & Aghajanian, 1977).
I t  is there fo re  possible th a t  an in h ib it io n  o f 5-HT reuptake by 
d ie ta ry  fac to rs  can lead to a decreased turnover and presumably to a 
release of 5-HT from the presynapse.
The current resu lts  have also shown th a t  when tryptophan was given 
e ith e r  alone or in combination with n ic o t in ic  acid and/or in s u l in ,  the  
concentrations of 5-HT and 5-H.IAA were fu r th e r  depleted (Chapter 3 ) .
Tryptophan is. also a precursor fo r  the synthesis of tryp.tamine (Saavedra & 
Axelrod, 1973; Marsden & Curzon, 1974), 5-m.ethoxytryptamine (Green, et al.
1973), melatonin (H ira ta ,  et a l . ,  1974.) and other tryptamine der iva tives  
(Carlsson, 1970) which are s truc tu ra l analogues to 5-HT. These compounds 
or probably tryptophan i t s e l f ,  may have some in h ib ito ry  effects on the  
release and reup.take of 5-HT at the receptor s i te s ,  presumably by com- . 
p e t i t io n  fo r  the reuptake mechanism, being themselves a c t iv e ly  transported  
in to  the serotonergic neurones.
Due to the in t r ic a t e  nature o f the mechanism involved a number of  
features re la ted  to changes in the physiological properties of 5-HT 
neurones in response to the n u tr it io n a l  fac to rs  require  a fu r th e r  
in ves tig a t io n . In add it ion , i t  would be o f  in te re s t  to evaluate to 
what extent these biochemical in te rrup tions  would be l i k e ly  to a f fe c t  
the conduction of nerve impulses along the serotonergic axons.
I t  is  hoped tha t  the work described in th is  thesis may contribute  
to the possible exp lo ita t io n  of n u t r i t io n a l  manipulations in the 
management of psych ia tr ic  disorders in which there are disturbances, of 
5-HT metabolism •
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